{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T23:47:53Z","timestamp":1795132073532,"version":"4.10.3"},"reference-count":371,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NIH\/NIA","award":["AG067473"],"award-info":[{"award-number":["AG067473"]}]},{"name":"NIH\/NINDS","award":["NS114221"],"award-info":[{"award-number":["NS114221"]}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["RX001473"],"award-info":[{"award-number":["RX001473"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["RX003865"],"award-info":[{"award-number":["RX003865"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Stroke and late-onset Alzheimer\u2019s disease (AD) are risk factors for each other; the comorbidity of these brain disorders in aging individuals represents a significant challenge in basic research and clinical practice. The similarities and differences between stroke and AD in terms of pathogenesis and pathophysiology, however, have rarely been comparably reviewed. Here, we discuss the research background and recent progresses that are important and informative for the comorbidity of stroke and late-onset AD and related dementia (ADRD). Glutamatergic NMDA receptor (NMDAR) activity and NMDAR-mediated Ca\n                    <jats:sup>2+<\/jats:sup>\n                    influx are essential for neuronal function and cell survival. An ischemic insult, however, can cause rapid increases in glutamate concentration and excessive activation of NMDARs, leading to swift Ca\n                    <jats:sup>2+<\/jats:sup>\n                    overload in neuronal cells and acute excitotoxicity within hours and days. On the other hand, mild upregulation of NMDAR activity, commonly seen in AD animal models and patients, is not immediately cytotoxic. Sustained NMDAR hyperactivity and Ca\n                    <jats:sup>2+<\/jats:sup>\n                    dysregulation lasting from months to years, nevertheless, can be pathogenic for slowly evolving events, i.e. degenerative excitotoxicity, in the development of AD\/ADRD. Specifically, Ca\n                    <jats:sup>2+<\/jats:sup>\n                    influx mediated by extrasynaptic NMDARs (eNMDARs) and a downstream pathway mediated by transient receptor potential cation channel subfamily M member (TRPM) are primarily responsible for excitotoxicity. On the other hand, the NMDAR subunit GluN3A plays a \u201cgatekeeper\u201d role in NMDAR activity and a neuroprotective role against both acute and chronic excitotoxicity. Thus, ischemic stroke and AD share an NMDAR- and Ca\n                    <jats:sup>2+<\/jats:sup>\n                    -mediated pathogenic mechanism that provides a common receptor target for preventive and possibly disease-modifying therapies. Memantine (MEM) preferentially blocks eNMDARs and was approved by the Federal Drug Administration (FDA) for symptomatic treatment of moderate-to-severe AD with variable efficacy. According to the pathogenic role of eNMDARs, it is conceivable that MEM and other eNMDAR antagonists should be administered much earlier, preferably during the presymptomatic phases of AD\/ADRD. This anti-AD treatment could simultaneously serve as a preconditioning strategy against stroke that attacks\u2009\u2265\u200950% of AD patients. Future research on the regulation of NMDARs, enduring control of eNMDARs, Ca\n                    <jats:sup>2+<\/jats:sup>\n                    homeostasis, and downstream events will provide a promising opportunity to understand and treat the comorbidity of AD\/ADRD and stroke.\n                  <\/jats:p>","DOI":"10.1186\/s13024-023-00636-1","type":"journal-article","created":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T08:03:15Z","timestamp":1688371395000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":170,"title":["Extrasynaptic NMDA receptors in acute and chronic excitotoxicity: implications for preventive treatments of ischemic stroke and late-onset Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1335-1398","authenticated-orcid":false,"given":"Shan P.","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Q.","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong S.","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soheila","family":"Pourkhodadad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,3]]},"reference":[{"key":"636_CR1","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.2147\/CLEP.S160764","volume":"10","author":"TF Imran","year":"2018","unstructured":"Imran TF, Posner D, Honerlaw J, Vassy JL, Song RJ, Ho YL, Kittner SJ, Liao KP, Cai T, O\u2019Donnell CJ, et al. A phenotyping algorithm to identify acute ischemic stroke accurately from a national biobank: the million veteran program. Clin Epidemiol. 2018;10:1509\u201321.","journal-title":"Clin Epidemiol"},{"key":"636_CR2","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3233\/JAD-160527","volume":"54","author":"M Vijayan","year":"2016","unstructured":"Vijayan M, Reddy PH. Stroke, vascular dementia, and Alzheimer\u2019s Disease: Molecular Links. J Alzheimers Dis. 2016;54:427\u201343.","journal-title":"J Alzheimers Dis"},{"key":"636_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12916-017-0779-7","volume":"15","author":"MD Mijajlovic","year":"2017","unstructured":"Mijajlovic MD, Pavlovic A, Brainin M, Heiss WD, Quinn TJ, Ihle-Hansen HB, Hermann DM, Assayag EB, Richard E, Thiel A, et al. Post-stroke dementia - a comprehensive review. BMC Med. 2017;15:11.","journal-title":"BMC Med"},{"key":"636_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000092923","volume":"22","author":"H Henon","year":"2006","unstructured":"Henon H, Pasquier F, Leys D. Poststroke dementia. Cerebrovasc Dis. 2006;22:61\u201370.","journal-title":"Cerebrovasc Dis"},{"key":"636_CR5","unstructured":"Association A. 2020 Alzheimer\u2019s disease facts and figures. Alzheimers Dement 2020, PMID: 32157811."},{"key":"636_CR6","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.clinthera.2020.02.018","volume":"42","author":"D Kempuraj","year":"2020","unstructured":"Kempuraj D, Ahmed ME, Selvakumar GP, Thangavel R, Raikwar SP, Zaheer SA, Iyer SS, Burton C, James D, Zaheer A. Psychological Stress-Induced Immune Response and Risk of Alzheimer\u2019s Disease in Veterans from Operation Enduring Freedom and Operation Iraqi Freedom. Clin Ther. 2020;42:974\u201382.","journal-title":"Clin Ther"},{"key":"636_CR7","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.bbadis.2016.01.015","volume":"1862","author":"RN Kalaria","year":"2016","unstructured":"Kalaria RN, Akinyemi R, Ihara M. Stroke injury, cognitive impairment and vascular dementia. Biochim Biophys Acta. 2016;1862:915\u201325.","journal-title":"Biochim Biophys Acta"},{"key":"636_CR8","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.3233\/JAD-201459","volume":"81","author":"E Zupanic","year":"2021","unstructured":"Zupanic E, von Euler M, Winblad B, Xu H, Secnik J, Kramberger MG, Religa D, Norrving B, Garcia-Ptacek S. Mortality after ischemic stroke in patients with Alzheimer\u2019s Disease Dementia and other Dementia Disorders. J Alzheimers Dis. 2021;81:1253\u201361.","journal-title":"J Alzheimers Dis"},{"key":"636_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4103\/bc.bc_18_20","volume":"6","author":"K Klomparens","year":"2020","unstructured":"Klomparens K, Ding Y. Updates on the association of brain injury and Alzheimer\u2019s disease. Brain Circ. 2020;6:65\u20139.","journal-title":"Brain Circ"},{"key":"636_CR10","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1586\/14737175.8.5.743","volume":"8","author":"DF Cechetto","year":"2008","unstructured":"Cechetto DF, Hachinski V, Whitehead SN. Vascular risk factors and Alzheimer\u2019s disease. Expert Rev Neurother. 2008;8:743\u201350.","journal-title":"Expert Rev Neurother"},{"key":"636_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.1993.tb18285.x","volume":"679","author":"MP Mattson","year":"1993","unstructured":"Mattson MP, Rydel RE, Lieberburg I, Smith-Swintosky VL. Altered calcium signaling and neuronal injury: stroke and Alzheimer\u2019s disease as examples. Ann N Y Acad Sci. 1993;679:1\u201321.","journal-title":"Ann N Y Acad Sci"},{"key":"636_CR12","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1001\/archneur.1997.00550220042012","volume":"54","author":"JW Olney","year":"1997","unstructured":"Olney JW, Wozniak DF, Farber NB. Excitotoxic neurodegeneration in Alzheimer disease. New hypothesis and new therapeutic strategies. Arch Neurol. 1997;54:1234\u201340.","journal-title":"Arch Neurol"},{"key":"636_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2018.07.019","volume":"72","author":"MD Howe","year":"2018","unstructured":"Howe MD, Atadja LA, Furr JW, Maniskas ME, Zhu L, McCullough LD, Urayama A. Fibronectin induces the perivascular deposition of cerebrospinal fluid-derived amyloid-beta in aging and after stroke. Neurobiol Aging. 2018;72:1\u201313.","journal-title":"Neurobiol Aging"},{"key":"636_CR14","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1182\/blood-2015-05-646117","volume":"127","author":"MY Shen","year":"2016","unstructured":"Shen MY, Chen FY, Hsu JF, Fu RH, Chang CM, Chang CT, Liu CH, Wu JR, Lee AS, Chan HC, et al. Plasma L5 levels are elevated in ischemic stroke patients and enhance platelet aggregation. Blood. 2016;127:1336\u201345.","journal-title":"Blood"},{"key":"636_CR15","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s40478-018-0603-4","volume":"6","author":"TV Nguyen","year":"2018","unstructured":"Nguyen TV, Hayes M, Zbesko JC, Frye JB, Congrove NR, Belichenko NP, McKay BS, Longo FM, Doyle KP. Alzheimer\u2019s associated amyloid and tau deposition co-localizes with a homeostatic myelin repair pathway in two mouse models of post-stroke mixed dementia. Acta Neuropathol Commun. 2018;6:100.","journal-title":"Acta Neuropathol Commun"},{"key":"636_CR16","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2174\/1566524043479248","volume":"4","author":"L Hoyte","year":"2004","unstructured":"Hoyte L, Barber PA, Buchan AM, Hill MD. The rise and fall of NMDA antagonists for ischemic stroke. Curr Mol Med. 2004;4:131\u20136.","journal-title":"Curr Mol Med"},{"key":"636_CR17","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.2174\/1389450123666220421124030","volume":"23","author":"Y Dai","year":"2022","unstructured":"Dai Y, Lei C, Zhang Z, Qi Y, Lao K, Gou X. Amyloid-beta targeted therapeutic approaches for Alzheimer\u2019s disease: long road ahead. Curr Drug Targets. 2022;23:1040\u201356.","journal-title":"Curr Drug Targets"},{"key":"636_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3233\/JAD-215699","volume":"87","author":"CK Kim","year":"2022","unstructured":"Kim CK, Lee YR, Ong L, Gold M, Kalali A, Sarkar J. Alzheimer\u2019s Disease: key insights from two decades of clinical trial failures. J Alzheimers Dis. 2022;87:83\u2013100.","journal-title":"J Alzheimers Dis"},{"key":"636_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/bc.bc_20_21","volume":"8","author":"R Mangal","year":"2022","unstructured":"Mangal R, Ding Y. Mini review: prospective therapeutic targets of Alzheimer\u2019s disease. Brain Circ. 2022;8:1\u20135.","journal-title":"Brain Circ"},{"key":"636_CR20","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1527-3458.2003.tb00254.x","volume":"9","author":"MA Rogawski","year":"2003","unstructured":"Rogawski MA, Wenk GL. The neuropharmacological basis for the use of memantine in the treatment of Alzheimer\u2019s disease. CNS Drug Rev. 2003;9:275\u2013308.","journal-title":"CNS Drug Rev"},{"key":"636_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/hast.1264","volume":"51","author":"LM Fleck","year":"2021","unstructured":"Fleck LM. Alzheimer\u2019s and Aducanumab: unjust profits and false hopes. Hastings Cent Rep. 2021;51:9\u201311.","journal-title":"Hastings Cent Rep"},{"key":"636_CR22","doi-asserted-by":"publisher","first-page":"329","DOI":"10.4140\/TCP.n.2022.329","volume":"37","author":"JM Yuksel","year":"2022","unstructured":"Yuksel JM, Noviasky J, Britton S. Aducanumab for Alzheimer\u2019s Disease: Summarized Data from EMERGE, ENGAGE, and PRIME Studies. Sr Care Pharm. 2022;37:329\u201334.","journal-title":"Sr Care Pharm"},{"key":"636_CR23","first-page":"197","volume":"9","author":"S Budd Haeberlein","year":"2022","unstructured":"Budd Haeberlein S, Aisen PS, Barkhof F, Chalkias S, Chen T, Cohen S, Dent G, Hansson O, Harrison K, von Hehn C, et al. Two Randomized phase 3 studies of Aducanumab in Early Alzheimer\u2019s Disease. J Prev Alzheimers Dis. 2022;9:197\u2013210.","journal-title":"J Prev Alzheimers Dis"},{"key":"636_CR24","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/alz.12213","volume":"17","author":"DS Knopman","year":"2021","unstructured":"Knopman DS, Jones DT, Greicius MD. Failure to demonstrate efficacy of aducanumab: an analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019. Alzheimers Dement. 2021;17:696\u2013701.","journal-title":"Alzheimers Dement"},{"key":"636_CR25","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/alz.12286","volume":"17","author":"LH Kuller","year":"2021","unstructured":"Kuller LH, Lopez OL. ENGAGE and EMERGE: Truth and consequences? Alzheimers Dement. 2021;17:692\u20135.","journal-title":"Alzheimers Dement"},{"key":"636_CR26","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1212\/WNL.0000000000008924","volume":"94","author":"R Waziry","year":"2020","unstructured":"Waziry R, Chibnik LB, Bos D, Ikram MK, Hofman A. Risk of hemorrhagic and ischemic stroke in patients with Alzheimer disease: a synthesis of the literature. Neurology. 2020;94:265\u201372.","journal-title":"Neurology"},{"key":"636_CR27","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1212\/WNL.0b013e31828250af","volume":"80","author":"NF Chi","year":"2013","unstructured":"Chi NF, Chien LN, Ku HL, Hu CJ, Chiou HY. Alzheimer disease and risk of stroke: a population-based cohort study. Neurology. 2013;80:705\u201311.","journal-title":"Neurology"},{"key":"636_CR28","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1001\/archneur.60.12.1707","volume":"60","author":"LS Honig","year":"2003","unstructured":"Honig LS, Tang MX, Albert S, Costa R, Luchsinger J, Manly J, Stern Y, Mayeux R. Stroke and the risk of Alzheimer disease. Arch Neurol. 2003;60:1707\u201312.","journal-title":"Arch Neurol"},{"key":"636_CR29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.coph.2005.12.002","volume":"6","author":"KW Muir","year":"2006","unstructured":"Muir KW. Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists. Curr Opin Pharmacol. 2006;6:53\u201360.","journal-title":"Curr Opin Pharmacol"},{"key":"636_CR30","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S1474-4422(02)00164-3","volume":"1","author":"C Ikonomidou","year":"2002","unstructured":"Ikonomidou C, Turski L. Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol. 2002;1:383\u20136.","journal-title":"Lancet Neurol"},{"key":"636_CR31","doi-asserted-by":"publisher","first-page":"579953","DOI":"10.3389\/fnins.2020.579953","volume":"14","author":"DW Choi","year":"2020","unstructured":"Choi DW. Excitotoxicity: still hammering the ischemic brain in 2020. Front Neurosci. 2020;14:579953.","journal-title":"Front Neurosci"},{"key":"636_CR32","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0166-2236(02)00040-1","volume":"26","author":"GE Hardingham","year":"2003","unstructured":"Hardingham GE, Bading H. The Yin and Yang of NMDA receptor signalling. Trends Neurosci. 2003;26:81\u20139.","journal-title":"Trends Neurosci"},{"key":"636_CR33","doi-asserted-by":"publisher","first-page":"926","DOI":"10.2174\/1570159X15666170116143743","volume":"15","author":"R Ricciarelli","year":"2017","unstructured":"Ricciarelli R, Fedele E. The amyloid Cascade Hypothesis in Alzheimer\u2019s Disease: it\u2019s Time to change our mind. Curr Neuropharmacol. 2017;15:926\u201335.","journal-title":"Curr Neuropharmacol"},{"key":"636_CR34","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/nn.4017","volume":"18","author":"K Herrup","year":"2015","unstructured":"Herrup K. The case for rejecting the amyloid cascade hypothesis. Nat Neurosci. 2015;18:794\u20139.","journal-title":"Nat Neurosci"},{"key":"636_CR35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fnins.2018.00025","volume":"12","author":"F Kametani","year":"2018","unstructured":"Kametani F, Hasegawa M. Reconsideration of amyloid hypothesis and tau hypothesis in Alzheimer\u2019s Disease. Front Neurosci. 2018;12:25.","journal-title":"Front Neurosci"},{"key":"636_CR36","first-page":"135","volume":"2","author":"GP Morris","year":"2014","unstructured":"Morris GP, Clark IA, Vissel B. Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer\u2019s disease. Acta Neuropathol Commun. 2014;2:135.","journal-title":"Acta Neuropathol Commun"},{"key":"636_CR37","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1750-1326-1-4","volume":"1","author":"KS Vetrivel","year":"2006","unstructured":"Vetrivel KS, Zhang YW, Xu H, Thinakaran G. Pathological and physiological functions of presenilins. Mol Neurodegener. 2006;1:4.","journal-title":"Mol Neurodegener"},{"key":"636_CR38","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/35050103","volume":"408","author":"G Chen","year":"2000","unstructured":"Chen G, Chen KS, Knox J, Inglis J, Bernard A, Martin SJ, Justice A, McConlogue L, Games D, Freedman SB, Morris RG. A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer\u2019s disease. Nature. 2000;408:975\u20139.","journal-title":"Nature"},{"key":"636_CR39","first-page":"307","volume":"152","author":"SA Frautschy","year":"1998","unstructured":"Frautschy SA, Yang F, Irrizarry M, Hyman B, Saido TC, Hsiao K, Cole GM. Microglial response to amyloid plaques in APPsw transgenic mice. Am J Pathol. 1998;152:307\u201317. PMID: 9422548.","journal-title":"Am J Pathol"},{"key":"636_CR40","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.bbr.2017.09.006","volume":"336","author":"LS Whyte","year":"2018","unstructured":"Whyte LS, Hemsley KM, Lau AA, Hassiotis S, Saito T, Saido TC, Hopwood JJ, Sargeant TJ. Reduction in open field activity in the absence of memory deficits in the app(NL-G-F) knock-in mouse model of Alzheimer\u2019s disease. Behav Brain Res. 2018;336:177\u201381.","journal-title":"Behav Brain Res"},{"key":"636_CR41","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0006-8993(94)90767-6","volume":"666","author":"L Mucke","year":"1994","unstructured":"Mucke L, Masliah E, Johnson WB, Ruppe MD, Alford M, Rockenstein EM, Forss-Petter S, Pietropaolo M, Mallory M, Abraham CR. Synaptotrophic effects of human amyloid beta protein precursors in the cortex of transgenic mice. Brain Res. 1994;666:151\u201367.","journal-title":"Brain Res"},{"key":"636_CR42","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3233\/JAD-1998-1202","volume":"1","author":"AM Kazee","year":"1998","unstructured":"Kazee AM, Johnson EM. Alzheimer\u2019s Disease Pathology in Non-Demented Elderly. J Alzheimers Dis. 1998;1:81\u20139.","journal-title":"J Alzheimers Dis"},{"key":"636_CR43","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1212\/WNL.55.3.370","volume":"55","author":"FA Schmitt","year":"2000","unstructured":"Schmitt FA, Davis DG, Wekstein DR, Smith CD, Ashford JW, Markesbery WR. Preclinical\u201d AD revisited: neuropathology of cognitively normal older adults. Neurology. 2000;55:370\u20136.","journal-title":"Neurology"},{"key":"636_CR44","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1212\/WNL.56.3.361","volume":"56","author":"WP Goldman","year":"2001","unstructured":"Goldman WP, Price JL, Storandt M, Grant EA, McKeel DW Jr, Rubin EH, Morris JC. Absence of cognitive impairment or decline in preclinical Alzheimer\u2019s disease. Neurology. 2001;56:361\u20137.","journal-title":"Neurology"},{"key":"636_CR45","doi-asserted-by":"publisher","first-page":"113945","DOI":"10.1016\/j.bcp.2020.113945","volume":"177","author":"K Mullane","year":"2020","unstructured":"Mullane K, Williams M. Alzheimer\u2019s disease beyond amyloid: can the repetitive failures of amyloid-targeted therapeutics inform future approaches to dementia drug discovery? Biochem Pharmacol. 2020;177:113945.","journal-title":"Biochem Pharmacol"},{"key":"636_CR46","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1002\/cpph.57","volume":"84","author":"K Mullane","year":"2019","unstructured":"Mullane K, Williams M. Preclinical models of Alzheimer\u2019s Disease: relevance and translational validity. Curr Protoc Pharmacol. 2019;84:e57.","journal-title":"Curr Protoc Pharmacol"},{"key":"636_CR47","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13195-017-0283-5","volume":"9","author":"PS Aisen","year":"2017","unstructured":"Aisen PS, Cummings J, Jack CR Jr, Morris JC, Sperling R, Frolich L, Jones RW, Dowsett SA, Matthews BR, Raskin J, et al. On the path to 2025: understanding the Alzheimer\u2019s disease continuum. Alzheimers Res Ther. 2017;9:60.","journal-title":"Alzheimers Res Ther"},{"key":"636_CR48","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13024-022-00523-1","volume":"17","author":"TE Golde","year":"2022","unstructured":"Golde TE. Alzheimer\u2019s disease - the journey of a healthy brain into organ failure. Mol Neurodegener. 2022;17:18.","journal-title":"Mol Neurodegener"},{"key":"636_CR49","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/alz.12562","volume":"18","author":"V Hachinski","year":"2022","unstructured":"Hachinski V, Avan A. A new definition of brain reserve. Alzheimers Dement. 2022;18:535\u20137.","journal-title":"Alzheimers Dement"},{"key":"636_CR50","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3233\/JAD-201540","volume":"81","author":"L Muller","year":"2021","unstructured":"Muller L, Kirschstein T, Kohling R, Kuhla A, Teipel S. Neuronal hyperexcitability in APPSWE\/PS1dE9 mouse models of Alzheimer\u2019s Disease. J Alzheimers Dis. 2021;81:855\u201369.","journal-title":"J Alzheimers Dis"},{"key":"636_CR51","doi-asserted-by":"publisher","first-page":"9318","DOI":"10.3390\/ijms21239318","volume":"21","author":"S Toniolo","year":"2020","unstructured":"Toniolo S, Sen A, Husain M. Modulation of Brain Hyperexcitability: potential new therapeutic approaches in Alzheimer\u2019s Disease. Int J Mol Sci. 2020;21:9318.","journal-title":"Int J Mol Sci"},{"key":"636_CR52","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.neuropharm.2007.07.013","volume":"53","author":"CG Parsons","year":"2007","unstructured":"Parsons CG, Stoffler A, Danysz W. Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system\u2013too little activation is bad, too much is even worse. Neuropharmacology. 2007;53:699\u2013723.","journal-title":"Neuropharmacology"},{"key":"636_CR53","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1007\/s13311-017-0541-z","volume":"14","author":"RP Haberman","year":"2017","unstructured":"Haberman RP, Branch A, Gallagher M. Targeting neural hyperactivity as a treatment to stem progression of late-onset Alzheimer\u2019s Disease. Neurotherapeutics. 2017;14:662\u201376.","journal-title":"Neurotherapeutics"},{"key":"636_CR54","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1146\/annurev-pharmtox-032320-015420","volume":"61","author":"S Ghatak","year":"2021","unstructured":"Ghatak S, Talantova M, McKercher SR, Lipton SA. Novel Therapeutic Approach for Excitatory\/Inhibitory imbalance in neurodevelopmental and neurodegenerative Diseases. Annu Rev Pharmacol Toxicol. 2021;61:701\u201321.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"636_CR55","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1186\/s13063-021-05404-4","volume":"22","author":"A Sen","year":"2021","unstructured":"Sen A, Akinola M, Tai XY, Symmonds M, Davis Jones G, Mura S, Galloway J, Hallam A, Chan JYC, Koychev I, et al. An investigation of Levetiracetam in Alzheimer\u2019s Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study. Trials. 2021;22:508.","journal-title":"Trials"},{"key":"636_CR56","doi-asserted-by":"publisher","first-page":"i5063","DOI":"10.1136\/bmj.i5063","volume":"354","author":"J Hopkins Tanne","year":"2016","unstructured":"Hopkins Tanne J. Approved drugs are to be studied for use in Alzheimer\u2019s disease. BMJ. 2016;354:i5063.","journal-title":"BMJ"},{"key":"636_CR57","doi-asserted-by":"publisher","first-page":"e3000851","DOI":"10.1371\/journal.pbio.3000851","volume":"18","author":"GA Rodriguez","year":"2020","unstructured":"Rodriguez GA, Barrett GM, Duff KE, Hussaini SA. Chemogenetic attenuation of neuronal activity in the entorhinal cortex reduces Abeta and tau pathology in the hippocampus. PLoS Biol. 2020;18:e3000851.","journal-title":"PLoS Biol"},{"key":"636_CR58","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1124\/pr.109.002451","volume":"62","author":"SF Traynelis","year":"2010","unstructured":"Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, Hansen KB, Yuan H, Myers SJ, Dingledine R. Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev. 2010;62:405\u201396.","journal-title":"Pharmacol Rev"},{"key":"636_CR59","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1113\/jphysiol.2013.264911","volume":"593","author":"AI Sobolevsky","year":"2015","unstructured":"Sobolevsky AI. Structure and gating of tetrameric glutamate receptors. J Physiol. 2015;593:29\u201338.","journal-title":"J Physiol"},{"key":"636_CR60","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.sbi.2019.05.004","volume":"57","author":"IH Greger","year":"2019","unstructured":"Greger IH, Mayer ML. Structural biology of glutamate receptor ion channels: towards an understanding of mechanism. Curr Opin Struct Biol. 2019;57:185\u201395.","journal-title":"Curr Opin Struct Biol"},{"key":"636_CR61","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.neuropharm.2013.04.014","volume":"74","author":"RG Morris","year":"2013","unstructured":"Morris RG. NMDA receptors and memory encoding. Neuropharmacology. 2013;74:32\u201340.","journal-title":"Neuropharmacology"},{"key":"636_CR62","doi-asserted-by":"publisher","first-page":"191","DOI":"10.33549\/physiolres.932678","volume":"63","author":"V Vyklicky","year":"2014","unstructured":"Vyklicky V, Korinek M, Smejkalova T, Balik A, Krausova B, Kaniakova M, Lichnerova K, Cerny J, Krusek J, Dittert I, et al. Structure, function, and pharmacology of NMDA receptor channels. Physiol Res. 2014;63:191\u2013203.","journal-title":"Physiol Res"},{"key":"636_CR63","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1111\/j.1460-9568.2011.07628.x","volume":"33","author":"P Paoletti","year":"2011","unstructured":"Paoletti P. Molecular basis of NMDA receptor functional diversity. Eur J Neurosci. 2011;33:1351\u201365.","journal-title":"Eur J Neurosci"},{"key":"636_CR64","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nrn.2016.92","volume":"17","author":"I Perez-Otano","year":"2016","unstructured":"Perez-Otano I, Larsen RS, Wesseling JF. Emerging roles of GluN3-containing NMDA receptors in the CNS. Nat Rev Neurosci. 2016;17:623\u201335.","journal-title":"Nat Rev Neurosci"},{"key":"636_CR65","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00441-006-0273-6","volume":"326","author":"G Kohr","year":"2006","unstructured":"Kohr G. NMDA receptor function: subunit composition versus spatial distribution. Cell Tissue Res. 2006;326:439\u201346.","journal-title":"Cell Tissue Res"},{"key":"636_CR66","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.neuron.2014.01.035","volume":"81","author":"KB Hansen","year":"2014","unstructured":"Hansen KB, Ogden KK, Yuan H, Traynelis SF. Distinct functional and pharmacological properties of Triheteromeric GluN1\/GluN2A\/GluN2B NMDA receptors. Neuron. 2014;81:1084\u201396.","journal-title":"Neuron"},{"key":"636_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cophys.2017.12.004","volume":"2","author":"D Stroebel","year":"2018","unstructured":"Stroebel D, Casado M, Paoletti P. Triheteromeric NMDA receptors: from structure to synaptic physiology. Curr Opin Physiol. 2018;2:1\u201312.","journal-title":"Curr Opin Physiol"},{"key":"636_CR68","first-page":"127","volume":"19","author":"EC Hammond","year":"1966","unstructured":"Hammond EC. Smoking in relation to the death rates of one million men and women. Natl Cancer Inst Monogr. 1966;19:127\u2013204. PMID: 5905667.","journal-title":"Natl Cancer Inst Monogr"},{"key":"636_CR69","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.tins.2011.11.010","volume":"35","author":"S Pachernegg","year":"2012","unstructured":"Pachernegg S, Strutz-Seebohm N, Hollmann M. GluN3 subunit-containing NMDA receptors: not just one-trick ponies. Trends Neurosci. 2012;35:240\u20139.","journal-title":"Trends Neurosci"},{"key":"636_CR70","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.pneurobio.2010.01.004","volume":"91","author":"MA Henson","year":"2010","unstructured":"Henson MA, Roberts AC, Perez-Otano I, Philpot BD. Influence of the NR3A subunit on NMDA receptor functions. Prog Neurobiol. 2010;91:23\u201337.","journal-title":"Prog Neurobiol"},{"key":"636_CR71","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.neuint.2010.08.009","volume":"57","author":"R Fukumori","year":"2010","unstructured":"Fukumori R, Takarada T, Nakamichi N, Kambe Y, Kawagoe H, Nakazato R, Yoneda Y. Requirement of both NR3A and NR3B subunits for dominant negative properties on Ca2 + mobilization mediated by acquired N-methyl-D-aspartate receptor channels into mitochondria. Neurochem Int. 2010;57:730\u20137.","journal-title":"Neurochem Int"},{"key":"636_CR72","doi-asserted-by":"publisher","first-page":"13156","DOI":"10.1523\/JNEUROSCI.2552-06.2006","volume":"26","author":"A Wada","year":"2006","unstructured":"Wada A, Takahashi H, Lipton SA, Chen HS. NR3A modulates the outer vestibule of the \u201cNMDA\u201d receptor channel. J Neurosci. 2006;26:13156\u201366.","journal-title":"J Neurosci"},{"key":"636_CR73","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.1038\/s41467-018-07236-4","volume":"9","author":"T Grand","year":"2018","unstructured":"Grand T, Abi Gerges S, David M, Diana MA, Paoletti P. Unmasking GluN1\/GluN3A excitatory glycine NMDA receptors. Nat Commun. 2018;9:4769.","journal-title":"Nat Commun"},{"key":"636_CR74","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1124\/jpet.107.123836","volume":"322","author":"CT Smothers","year":"2007","unstructured":"Smothers CT, Woodward JJ. Pharmacological characterization of glycine-activated currents in HEK 293 cells expressing N-methyl-D-aspartate NR1 and NR3 subunits. J Pharmacol Exp Ther. 2007;322:739\u201348.","journal-title":"J Pharmacol Exp Ther"},{"key":"636_CR75","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1556\/2006.7.2018.35","volume":"7","author":"MS Sadat-Shirazi","year":"2018","unstructured":"Sadat-Shirazi MS, Vousooghi N, Alizadeh B, Makki SM, Zarei SZ, Nazari S, Zarrindast MR. Expression of NMDA receptor subunits in human blood lymphocytes: a peripheral biomarker in online computer game addiction. J Behav Addict. 2018;7:260\u20138.","journal-title":"J Behav Addict"},{"key":"636_CR76","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1111\/j.1476-5381.2011.01374.x","volume":"163","author":"O Palygin","year":"2011","unstructured":"Palygin O, Lalo U, Pankratov Y. Distinct pharmacological and functional properties of NMDA receptors in mouse cortical astrocytes. Br J Pharmacol. 2011;163:1755\u201366.","journal-title":"Br J Pharmacol"},{"key":"636_CR77","doi-asserted-by":"publisher","first-page":"F44","DOI":"10.1152\/ajprenal.00666.2010","volume":"301","author":"A Sproul","year":"2011","unstructured":"Sproul A, Steele SL, Thai TL, Yu S, Klein JD, Sands JM, Bell PD. N-methyl-D-aspartate receptor subunit NR3a expression and function in principal cells of the collecting duct. Am J Physiol Renal Physiol. 2011;301:F44\u201354.","journal-title":"Am J Physiol Renal Physiol"},{"key":"636_CR78","doi-asserted-by":"publisher","first-page":"F42","DOI":"10.1152\/ajprenal.00211.2011","volume":"301","author":"J Frokiaer","year":"2011","unstructured":"Frokiaer J. Collecting duct expression of N-methyl-D-aspartate receptor subtype NR3a regulates urinary concentrating capacity. Am J Physiol Renal Physiol. 2011;301:F42\u201343.","journal-title":"Am J Physiol Renal Physiol"},{"key":"636_CR79","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nn835","volume":"5","author":"GE Hardingham","year":"2002","unstructured":"Hardingham GE, Fukunaga Y, Bading H. Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosci. 2002;5:405\u201314.","journal-title":"Nat Neurosci"},{"key":"636_CR80","doi-asserted-by":"publisher","first-page":"20130601","DOI":"10.1098\/rstb.2013.0601","volume":"369","author":"T Papouin","year":"2014","unstructured":"Papouin T, Oliet SH. Organization, control and function of extrasynaptic NMDA receptors. Philos Trans R Soc Lond B Biol Sci. 2014;369:20130601.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"636_CR81","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.neuropharm.2013.03.030","volume":"74","author":"Q Zhou","year":"2013","unstructured":"Zhou Q, Sheng M. NMDA receptors in nervous system diseases. Neuropharmacology. 2013;74:69\u201375.","journal-title":"Neuropharmacology"},{"key":"636_CR82","doi-asserted-by":"publisher","first-page":"4958","DOI":"10.1523\/JNEUROSCI.23-12-04958.2003","volume":"23","author":"SG Brickley","year":"2003","unstructured":"Brickley SG, Misra C, Mok MH, Mishina M, Cull-Candy SG. NR2B and NR2D subunits coassemble in cerebellar golgi cells to form a distinct NMDA receptor subtype restricted to extrasynaptic sites. J Neurosci. 2003;23:4958\u201366.","journal-title":"J Neurosci"},{"key":"636_CR83","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s11064-015-1794-8","volume":"41","author":"KS Wee","year":"2016","unstructured":"Wee KS, Tan FC, Cheong YP, Khanna S, Low CM. Ontogenic Profile and synaptic distribution of GluN3 proteins in the rat brain and hippocampal neurons. Neurochem Res. 2016;41:290\u20137.","journal-title":"Neurochem Res"},{"key":"636_CR84","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.neuroscience.2012.10.061","volume":"230","author":"LK Berg","year":"2013","unstructured":"Berg LK, Larsson M, Morland C, Gundersen V. Pre- and postsynaptic localization of NMDA receptor subunits at hippocampal mossy fibre synapses. Neuroscience. 2013;230:139\u201350.","journal-title":"Neuroscience"},{"key":"636_CR85","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1615\/CritRevNeurobiol.v18.i1-2.80","volume":"18","author":"JF MacDonald","year":"2006","unstructured":"MacDonald JF, Jackson MF, Beazely MA. Hippocampal long-term synaptic plasticity and signal amplification of NMDA receptors. Crit Rev Neurobiol. 2006;18:71\u201384.","journal-title":"Crit Rev Neurobiol"},{"key":"636_CR86","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1126\/science.1096615","volume":"304","author":"L Liu","year":"2004","unstructured":"Liu L, Wong TP, Pozza MF, Lingenhoehl K, Wang Y, Sheng M, Auberson YP, Wang YT. Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity. Science. 2004;304:1021\u20134.","journal-title":"Science"},{"key":"636_CR87","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.cell.2012.06.029","volume":"150","author":"T Papouin","year":"2012","unstructured":"Papouin T, Ladepeche L, Ruel J, Sacchi S, Labasque M, Hanini M, Groc L, Pollegioni L, Mothet JP, Oliet SH. Synaptic and extrasynaptic NMDA receptors are gated by different endogenous coagonists. Cell. 2012;150:633\u201346.","journal-title":"Cell"},{"key":"636_CR88","doi-asserted-by":"publisher","first-page":"7821","DOI":"10.1523\/JNEUROSCI.1697-04.2004","volume":"24","author":"PV Massey","year":"2004","unstructured":"Massey PV, Johnson BE, Moult PR, Auberson YP, Brown MW, Molnar E, Collingridge GL, Bashir ZI. Differential roles of NR2A and NR2B-containing NMDA receptors in cortical long-term potentiation and long-term depression. J Neurosci. 2004;24:7821\u20138.","journal-title":"J Neurosci"},{"key":"636_CR89","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.brainresbull.2012.12.003","volume":"93","author":"DD Liu","year":"2013","unstructured":"Liu DD, Yang Q, Li ST. Activation of extrasynaptic NMDA receptors induces LTD in rat hippocampal CA1 neurons. Brain Res Bull. 2013;93:10\u20136.","journal-title":"Brain Res Bull"},{"key":"636_CR90","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1038\/s41598-017-03287-7","volume":"7","author":"Q Yang","year":"2017","unstructured":"Yang Q, Zhu G, Liu D, Ju JG, Liao ZH, Xiao YX, Zhang Y, Chao N, Wang J, Li W, et al. Extrasynaptic NMDA receptor dependent long-term potentiation of hippocampal CA1 pyramidal neurons. Sci Rep. 2017;7:3045.","journal-title":"Sci Rep"},{"key":"636_CR91","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nrn3504","volume":"14","author":"P Paoletti","year":"2013","unstructured":"Paoletti P, Bellone C, Zhou Q. NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nat Rev Neurosci. 2013;14:383\u2013400.","journal-title":"Nat Rev Neurosci"},{"key":"636_CR92","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3389\/fncel.2015.00095","volume":"9","author":"J von Engelhardt","year":"2015","unstructured":"von Engelhardt J, Bocklisch C, Tonges L, Herb A, Mishina M, Monyer H. GluN2D-containing NMDA receptors-mediate synaptic currents in hippocampal interneurons and pyramidal cells in juvenile mice. Front Cell Neurosci. 2015;9:95.","journal-title":"Front Cell Neurosci"},{"key":"636_CR93","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1523\/JNEUROSCI.2065-21.2022","volume":"42","author":"L Yao","year":"2022","unstructured":"Yao L, Rong Y, Ma X, Li H, Deng D, Chen Y, Yang S, Peng T, Ye T, Liang F, et al. Extrasynaptic NMDA receptors bidirectionally modulate intrinsic excitability of inhibitory neurons. J Neurosci. 2022;42:3066\u201379.","journal-title":"J Neurosci"},{"key":"636_CR94","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/ejn.13128","volume":"43","author":"I Riebe","year":"2016","unstructured":"Riebe I, Seth H, Culley G, Dosa Z, Radi S, Strand K, Frojd V, Hanse E. Tonically active NMDA receptors\u2013a signalling mechanism critical for interneuronal excitability in the CA1 stratum radiatum. Eur J Neurosci. 2016;43:169\u201378.","journal-title":"Eur J Neurosci"},{"key":"636_CR95","doi-asserted-by":"crossref","unstructured":"Garst-Orozco J, Malik R, Lanz TA, Weber ML, Xi H, Arion D, Enwright JF 3rd, Lewis DA, O\u2019Donnell P, Sohal VS, Buhl DL. GluN2D-mediated excitatory drive onto medial prefrontal cortical PV + fast-spiking inhibitory interneurons. PLoS ONE. 2020;15:e0233895.","DOI":"10.1371\/journal.pone.0233895"},{"key":"636_CR96","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.neuropharm.2014.09.013","volume":"89","author":"M Garcia-Munoz","year":"2015","unstructured":"Garcia-Munoz M, Lopez-Huerta VG, Carrillo-Reid L, Arbuthnott GW. Extrasynaptic glutamate NMDA receptors: key players in striatal function. Neuropharmacology. 2015;89:54\u201363.","journal-title":"Neuropharmacology"},{"key":"636_CR97","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.neuropharm.2006.07.005","volume":"52","author":"W Morishita","year":"2007","unstructured":"Morishita W, Lu W, Smith GB, Nicoll RA, Bear MF, Malenka RC. Activation of NR2B-containing NMDA receptors is not required for NMDA receptor-dependent long-term depression. Neuropharmacology. 2007;52:71\u20136.","journal-title":"Neuropharmacology"},{"key":"636_CR98","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.neuron.2005.08.034","volume":"48","author":"A Barria","year":"2005","unstructured":"Barria A, Malinow R. NMDA receptor subunit composition controls synaptic plasticity by regulating binding to CaMKII. Neuron. 2005;48:289\u2013301.","journal-title":"Neuron"},{"key":"636_CR99","doi-asserted-by":"publisher","first-page":"4258","DOI":"10.1096\/fj.08-107268","volume":"22","author":"F Leveille","year":"2008","unstructured":"Leveille F, El Gaamouch F, Gouix E, Lecocq M, Lobner D, Nicole O, Buisson A. Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors. FASEB J. 2008;22:4258\u201371.","journal-title":"FASEB J"},{"key":"636_CR100","doi-asserted-by":"publisher","first-page":"9854","DOI":"10.1073\/pnas.0903546106","volume":"106","author":"RI Stanika","year":"2009","unstructured":"Stanika RI, Pivovarova NB, Brantner CA, Watts CA, Winters CA, Andrews SB. Coupling diverse routes of calcium entry to mitochondrial dysfunction and glutamate excitotoxicity. Proc Natl Acad Sci U S A. 2009;106:9854\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"636_CR101","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1515\/rns.2011.029","volume":"22","author":"K Bordji","year":"2011","unstructured":"Bordji K, Becerril-Ortega J, Buisson A. Synapses, NMDA receptor activity and neuronal abeta production in Alzheimer\u2019s disease. Rev Neurosci. 2011;22:285\u201394.","journal-title":"Rev Neurosci"},{"key":"636_CR102","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/nrn2229","volume":"8","author":"SA Lipton","year":"2007","unstructured":"Lipton SA. Pathologically activated therapeutics for neuroprotection. Nat Rev Neurosci. 2007;8:803\u20138.","journal-title":"Nat Rev Neurosci"},{"key":"636_CR103","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1756-6606-6-34","volume":"6","author":"N Bai","year":"2013","unstructured":"Bai N, Aida T, Yanagisawa M, Katou S, Sakimura K, Mishina M, Tanaka K. NMDA receptor subunits have different roles in NMDA-induced neurotoxicity in the retina. Mol Brain. 2013;6:34.","journal-title":"Mol Brain"},{"key":"636_CR104","doi-asserted-by":"publisher","first-page":"6732","DOI":"10.1523\/JNEUROSCI.6371-11.2012","volume":"32","author":"CM Wroge","year":"2012","unstructured":"Wroge CM, Hogins J, Eisenman L, Mennerick S. Synaptic NMDA receptors mediate hypoxic excitotoxic death. J Neurosci. 2012;32:6732\u201342.","journal-title":"J Neurosci"},{"key":"636_CR105","doi-asserted-by":"publisher","first-page":"24151","DOI":"10.1074\/jbc.M113.482000","volume":"288","author":"X Zhou","year":"2013","unstructured":"Zhou X, Ding Q, Chen Z, Yun H, Wang H. Involvement of the GluN2A and GluN2B subunits in synaptic and extrasynaptic N-methyl-D-aspartate receptor function and neuronal excitotoxicity. J Biol Chem. 2013;288:24151\u20139.","journal-title":"J Biol Chem"},{"key":"636_CR106","doi-asserted-by":"publisher","first-page":"e560","DOI":"10.1038\/cddis.2013.82","volume":"4","author":"X Zhou","year":"2013","unstructured":"Zhou X, Hollern D, Liao J, Andrechek E, Wang H. NMDA receptor-mediated excitotoxicity depends on the coactivation of synaptic and extrasynaptic receptors. Cell Death Dis. 2013;4:e560.","journal-title":"Cell Death Dis"},{"key":"636_CR107","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.neuron.2014.03.030","volume":"82","author":"MP Parsons","year":"2014","unstructured":"Parsons MP, Raymond LA. Extrasynaptic NMDA receptor involvement in central nervous system disorders. Neuron. 2014;82:279\u201393.","journal-title":"Neuron"},{"key":"636_CR108","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1084\/jem.20161673","volume":"214","author":"H Bading","year":"2017","unstructured":"Bading H. Therapeutic targeting of the pathological triad of extrasynaptic NMDA receptor signaling in neurodegenerations. J Exp Med. 2017;214:569\u201378.","journal-title":"J Exp Med"},{"key":"636_CR109","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/nm.2056","volume":"15","author":"S Okamoto","year":"2009","unstructured":"Okamoto S, Pouladi MA, Talantova M, Yao D, Xia P, Ehrnhoefer DE, Zaidi R, Clemente A, Kaul M, Graham RK, et al. Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin. Nat Med. 2009;15:1407\u201313.","journal-title":"Nat Med"},{"key":"636_CR110","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1002\/neu.480230915","volume":"23","author":"DW Choi","year":"1992","unstructured":"Choi DW. Excitotoxic cell death. J Neurobiol. 1992;23:1261\u201376.","journal-title":"J Neurobiol"},{"key":"636_CR111","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/ana.410190202","volume":"19","author":"SM Rothman","year":"1986","unstructured":"Rothman SM, Olney JW. Glutamate and the pathophysiology of hypoxic\u2013ischemic brain damage. Ann Neurol. 1986;19:105\u201311.","journal-title":"Ann Neurol"},{"key":"636_CR112","doi-asserted-by":"publisher","first-page":"37033","DOI":"10.1038\/srep37033","volume":"6","author":"C Chung","year":"2016","unstructured":"Chung C, Marson JD, Zhang QG, Kim J, Wu WH, Brann DW, Chen BS. Neuroprotection mediated through GluN2C-Containing N-methyl-D-aspartate (NMDA) receptors following ischemia. Sci Rep. 2016;6:37033.","journal-title":"Sci Rep"},{"key":"636_CR113","doi-asserted-by":"crossref","unstructured":"Petralia RS. Distribution of extrasynaptic NMDA receptors on neurons. ScientificWorldJournal 2012, 2012:267120.","DOI":"10.1100\/2012\/267120"},{"key":"636_CR114","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nn1680","volume":"9","author":"I Perez-Otano","year":"2006","unstructured":"Perez-Otano I, Lujan R, Tavalin SJ, Plomann M, Modregger J, Liu XB, Jones EG, Heinemann SF, Lo DC, Ehlers MD. Endocytosis and synaptic removal of NR3A-containing NMDA receptors by PACSIN1\/syndapin1. Nat Neurosci. 2006;9:611\u201321.","journal-title":"Nat Neurosci"},{"key":"636_CR115","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.neuron.2009.06.016","volume":"63","author":"AC Roberts","year":"2009","unstructured":"Roberts AC, Diez-Garcia J, Rodriguiz RM, Lopez IP, Lujan R, Martinez-Turrillas R, Pico E, Henson MA, Bernardo DR, Jarrett TM, et al. Downregulation of NR3A-containing NMDARs is required for synapse maturation and memory consolidation. Neuron. 2009;63:342\u201356.","journal-title":"Neuron"},{"key":"636_CR116","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1007\/s00429-015-1099-3","volume":"221","author":"JH Lee","year":"2016","unstructured":"Lee JH, Wei L, Deveau TC, Gu X, Yu SP. Expression of the NMDA receptor subunit GluN3A (NR3A) in the olfactory system and its regulatory role on olfaction in the adult mouse. Brain Struct Funct. 2016;221:3259\u201373.","journal-title":"Brain Struct Funct"},{"key":"636_CR117","doi-asserted-by":"publisher","first-page":"C570","DOI":"10.1152\/ajpcell.00353.2014","volume":"308","author":"JH Lee","year":"2015","unstructured":"Lee JH, Wei ZZ, Chen D, Gu X, Wei L, Yu SP. A neuroprotective role of the NMDA receptor subunit GluN3A (NR3A) in ischemic stroke of the adult mouse. Am J Physiol Cell Physiol. 2015;308:C570\u2013577.","journal-title":"Am J Physiol Cell Physiol"},{"key":"636_CR118","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1113\/jphysiol.2012.239251","volume":"591","author":"O Mohamad","year":"2013","unstructured":"Mohamad O, Song M, Wei L, Yu SP. Regulatory roles of the NMDA receptor GluN3A subunit in locomotion, pain perception and cognitive functions in adult mice. J Physiol. 2013;591:149\u201368.","journal-title":"J Physiol"},{"key":"636_CR119","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0304-3940(01)02524-1","volume":"321","author":"M Eriksson","year":"2002","unstructured":"Eriksson M, Nilsson A, Froelich-Fabre S, Akesson E, Dunker J, Seiger A, Folkesson R, Benedikz E, Sundstrom E. Cloning and expression of the human N-methyl-D-aspartate receptor subunit NR3A. Neurosci Lett. 2002;321:177\u201381.","journal-title":"Neurosci Lett"},{"key":"636_CR120","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.brainres.2007.09.008","volume":"1186","author":"A Nilsson","year":"2007","unstructured":"Nilsson A, Eriksson M, Muly EC, Akesson E, Samuelsson EB, Bogdanovic N, Benedikz E, Sundstrom E. Analysis of NR3A receptor subunits in human native NMDA receptors. Brain Res. 2007;1186:102\u201312.","journal-title":"Brain Res"},{"key":"636_CR121","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1152\/jn.01044.2006","volume":"99","author":"G Tong","year":"2008","unstructured":"Tong G, Takahashi H, Tu S, Shin Y, Talantova M, Zago W, Xia P, Nie Z, Goetz T, Zhang D, et al. Modulation of NMDA receptor properties and synaptic transmission by the NR3A subunit in mouse hippocampal and cerebrocortical neurons. J Neurophysiol. 2008;99:122\u201332.","journal-title":"J Neurophysiol"},{"key":"636_CR122","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.nbd.2012.07.001","volume":"48","author":"R Martinez-Turrillas","year":"2012","unstructured":"Martinez-Turrillas R, Puerta E, Chowdhury D, Marco S, Watanabe M, Aguirre N, Perez-Otano I. The NMDA receptor subunit GluN3A protects against 3-nitroproprionic-induced striatal lesions via inhibition of calpain activation. Neurobiol Dis. 2012;48:290\u20138.","journal-title":"Neurobiol Dis"},{"key":"636_CR123","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1523\/JNEUROSCI.20-01-00022.2000","volume":"20","author":"R Sattler","year":"2000","unstructured":"Sattler R, Xiong Z, Lu WY, MacDonald JF, Tymianski M. Distinct roles of synaptic and extrasynaptic NMDA receptors in excitotoxicity. J Neurosci. 2000;20:22\u201333.","journal-title":"J Neurosci"},{"key":"636_CR124","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1523\/JNEUROSCI.0116-07.2007","volume":"27","author":"Y Liu","year":"2007","unstructured":"Liu Y, Wong TP, Aarts M, Rooyakkers A, Liu L, Lai TW, Wu DC, Lu J, Tymianski M, Craig AM, Wang YT. NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. J Neurosci. 2007;27:2846\u201357.","journal-title":"J Neurosci"},{"key":"636_CR125","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.mcn.2011.05.001","volume":"48","author":"CM Gladding","year":"2011","unstructured":"Gladding CM, Raymond LA. Mechanisms underlying NMDA receptor synaptic\/extrasynaptic distribution and function. Mol Cell Neurosci. 2011;48:308\u201320.","journal-title":"Mol Cell Neurosci"},{"key":"636_CR126","doi-asserted-by":"publisher","first-page":"5260","DOI":"10.1523\/JNEUROSCI.1067-09.2009","volume":"29","author":"N Nakanishi","year":"2009","unstructured":"Nakanishi N, Tu S, Shin Y, Cui J, Kurokawa T, Zhang D, Chen HS, Tong G, Lipton SA. Neuroprotection by the NR3A subunit of the NMDA receptor. J Neurosci. 2009;29:5260\u20135.","journal-title":"J Neurosci"},{"key":"636_CR127","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/alz.12398","volume":"18","author":"W Zhong","year":"2022","unstructured":"Zhong W, Wu A, Berglund K, Gu X, Jiang MQ, Talati J, Zhao J, Wei L, Yu SP. Pathogenesis of sporadic Alzheimer\u2019s disease by deficiency of NMDA receptor subunit GluN3A. Alzheimers Dement. 2022;18:222\u201339.","journal-title":"Alzheimers Dement"},{"key":"636_CR128","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1038\/s41596-019-0143-9","volume":"14","author":"CD Durst","year":"2019","unstructured":"Durst CD, Wiegert JS, Helassa N, Kerruth S, Coates C, Schulze C, Geeves MA, Torok K, Oertner TG. High-speed imaging of glutamate release with genetically encoded sensors. Nat Protoc. 2019;14:1401\u201324.","journal-title":"Nat Protoc"},{"key":"636_CR129","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.neuroscience.2009.03.077","volume":"162","author":"G Szapiro","year":"2009","unstructured":"Szapiro G, Barbour B. Parasynaptic signalling by fast neurotransmitters: the cerebellar cortex. Neuroscience. 2009;162:644\u201355.","journal-title":"Neuroscience"},{"key":"636_CR130","doi-asserted-by":"publisher","first-page":"e70791","DOI":"10.1371\/journal.pone.0070791","volume":"8","author":"JP Kessler","year":"2013","unstructured":"Kessler JP. Control of cleft glutamate concentration and glutamate spill-out by perisynaptic glia: uptake and diffusion barriers. PLoS ONE. 2013;8:e70791.","journal-title":"PLoS ONE"},{"key":"636_CR131","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.pbb.2007.09.004","volume":"90","author":"M van der Zeyden","year":"2008","unstructured":"van der Zeyden M, Oldenziel WH, Rea K, Cremers TI, Westerink BH. Microdialysis of GABA and glutamate: analysis, interpretation and comparison with microsensors. Pharmacol Biochem Behav. 2008;90:135\u201347.","journal-title":"Pharmacol Biochem Behav"},{"key":"636_CR132","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/nn1246","volume":"7","author":"P Bezzi","year":"2004","unstructured":"Bezzi P, Gundersen V, Galbete JL, Seifert G, Steinhauser C, Pilati E, Volterra A. Astrocytes contain a vesicular compartment that is competent for regulated exocytosis of glutamate. Nat Neurosci. 2004;7:613\u201320.","journal-title":"Nat Neurosci"},{"key":"636_CR133","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrn2803","volume":"11","author":"NB Hamilton","year":"2010","unstructured":"Hamilton NB, Attwell D. Do astrocytes really exocytose neurotransmitters? Nat Rev Neurosci. 2010;11:227\u201338.","journal-title":"Nat Rev Neurosci"},{"key":"636_CR134","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.neuron.2004.08.011","volume":"43","author":"T Fellin","year":"2004","unstructured":"Fellin T, Pascual O, Gobbo S, Pozzan T, Haydon PG, Carmignoto G. Neuronal synchrony mediated by astrocytic glutamate through activation of extrasynaptic NMDA receptors. Neuron. 2004;43:729\u201343.","journal-title":"Neuron"},{"key":"636_CR135","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.neuroscience.2008.03.074","volume":"158","author":"LH Bergersen","year":"2009","unstructured":"Bergersen LH, Gundersen V. Morphological evidence for vesicular glutamate release from astrocytes. Neuroscience. 2009;158:260\u20135.","journal-title":"Neuroscience"},{"key":"636_CR136","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1523\/JNEUROSCI.5486-08.2009","volume":"29","author":"MB Dash","year":"2009","unstructured":"Dash MB, Douglas CL, Vyazovskiy VV, Cirelli C, Tononi G. Long-term homeostasis of extracellular glutamate in the rat cerebral cortex across sleep and waking states. J Neurosci. 2009;29:620\u20139.","journal-title":"J Neurosci"},{"key":"636_CR137","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jneumeth.2006.08.003","volume":"160","author":"WH Oldenziel","year":"2007","unstructured":"Oldenziel WH, van der Zeyden M, Dijkstra G, Ghijsen WE, Karst H, Cremers TI, Westerink BH. Monitoring extracellular glutamate in hippocampal slices with a microsensor. J Neurosci Methods. 2007;160:37\u201344.","journal-title":"J Neurosci Methods"},{"key":"636_CR138","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1124\/jpet.107.131698","volume":"324","author":"KN Hascup","year":"2008","unstructured":"Hascup KN, Hascup ER, Pomerleau F, Huettl P, Gerhardt GA. Second-by-second measures of L-glutamate in the prefrontal cortex and striatum of freely moving mice. J Pharmacol Exp Ther. 2008;324:725\u201331.","journal-title":"J Pharmacol Exp Ther"},{"key":"636_CR139","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1111\/j.1471-4159.2010.07066.x","volume":"115","author":"ER Hascup","year":"2010","unstructured":"Hascup ER, Hascup KN, Stephens M, Pomerleau F, Huettl P, Gratton A, Gerhardt GA. Rapid microelectrode measurements and the origin and regulation of extracellular glutamate in rat prefrontal cortex. J Neurochem. 2010;115:1608\u201320.","journal-title":"J Neurochem"},{"key":"636_CR140","doi-asserted-by":"publisher","first-page":"9736","DOI":"10.1523\/JNEUROSCI.3009-07.2007","volume":"27","author":"MA Herman","year":"2007","unstructured":"Herman MA, Jahr CE. Extracellular glutamate concentration in hippocampal slice. J Neurosci. 2007;27:9736\u201341.","journal-title":"J Neurosci"},{"key":"636_CR141","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1113\/JP278362","volume":"598","author":"A Moldavski","year":"2020","unstructured":"Moldavski A, Behr J, Bading H, Bengtson CP. A novel method using ambient glutamate for the electrophysiological quantification of extrasynaptic NMDA receptor function in acute brain slices. J Physiol. 2020;598:633\u201350.","journal-title":"J Physiol"},{"key":"636_CR142","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1523\/JNEUROSCI.12-01-00056.1992","volume":"12","author":"PA Rosenberg","year":"1992","unstructured":"Rosenberg PA, Amin S, Leitner M. Glutamate uptake disguises neurotoxic potency of glutamate agonists in cerebral cortex in dissociated cell culture. J Neurosci. 1992;12:56\u201361.","journal-title":"J Neurosci"},{"key":"636_CR143","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.1172\/JCI71886","volume":"124","author":"FN Soria","year":"2014","unstructured":"Soria FN, Perez-Samartin A, Martin A, Gona KB, Llop J, Szczupak B, Chara JC, Matute C, Domercq M. Extrasynaptic glutamate release through cystine\/glutamate antiporter contributes to ischemic damage. J Clin Invest. 2014;124:3645\u201355.","journal-title":"J Clin Invest"},{"key":"636_CR144","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1111\/j.1471-4159.1993.tb13387.x","volume":"60","author":"B Moghaddam","year":"1993","unstructured":"Moghaddam B. Stress preferentially increases extraneuronal levels of excitatory amino acids in the prefrontal cortex: comparison to hippocampus and basal ganglia. J Neurochem. 1993;60:1650\u20137.","journal-title":"J Neurochem"},{"key":"636_CR145","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/0006-8993(86)91230-8","volume":"384","author":"J Lerma","year":"1986","unstructured":"Lerma J, Herranz AS, Herreras O, Abraira V, Martin del Rio R. In vivo determination of extracellular concentration of amino acids in the rat hippocampus. A method based on brain dialysis and computerized analysis. Brain Res. 1986;384:145\u201355.","journal-title":"Brain Res"},{"key":"636_CR146","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0166-2236(99)01401-0","volume":"22","author":"U Dirnagl","year":"1999","unstructured":"Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999;22:391\u20137.","journal-title":"Trends Neurosci"},{"key":"636_CR147","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1007\/s00018-018-2837-5","volume":"75","author":"B Pal","year":"2018","unstructured":"Pal B. Involvement of extrasynaptic glutamate in physiological and pathophysiological changes of neuronal excitability. Cell Mol Life Sci. 2018;75:2917\u201349.","journal-title":"Cell Mol Life Sci"},{"key":"636_CR148","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40035-021-00278-7","volume":"11","author":"M Verma","year":"2022","unstructured":"Verma M, Lizama BN, Chu CT. Excitotoxicity, calcium and mitochondria: a triad in synaptic neurodegeneration. Transl Neurodegener. 2022;11:3.","journal-title":"Transl Neurodegener"},{"key":"636_CR149","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1002\/jnr.24810","volume":"99","author":"KJ Brymer","year":"2021","unstructured":"Brymer KJ, Barnes JR, Parsons MP. Entering a new era of quantifying glutamate clearance in health and disease. J Neurosci Res. 2021;99:1598\u2013617.","journal-title":"J Neurosci Res"},{"key":"636_CR150","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/jnr.490410416","volume":"41","author":"C Arias","year":"1995","unstructured":"Arias C, Arrieta I, Tapia R. beta-amyloid peptide fragment 25\u201335 potentiates the calcium-dependent release of excitatory amino acids from depolarized hippocampal slices. J Neurosci Res. 1995;41:561\u20136.","journal-title":"J Neurosci Res"},{"key":"636_CR151","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/0014-4827(77)90012-X","volume":"109","author":"V Gross","year":"1977","unstructured":"Gross V, Weiss E, Northemann W, Scheurlen M, Heinrich PC. Comparative studies of the effects of galactosamine and actinomycin D on nuclear ribonucleoprotein particles from rat liver. Exp Cell Res. 1977;109:331\u20139.","journal-title":"Exp Cell Res"},{"key":"636_CR152","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.nbd.2003.12.006","volume":"15","author":"P Fernandez-Tome","year":"2004","unstructured":"Fernandez-Tome P, Brera B, Arevalo MA, de Ceballos ML. Beta-amyloid25-35 inhibits glutamate uptake in cultured neurons and astrocytes: modulation of uptake as a survival mechanism. Neurobiol Dis. 2004;15:580\u20139.","journal-title":"Neurobiol Dis"},{"key":"636_CR153","doi-asserted-by":"publisher","first-page":"E2518","DOI":"10.1073\/pnas.1306832110","volume":"110","author":"M Talantova","year":"2013","unstructured":"Talantova M, Sanz-Blasco S, Zhang X, Xia P, Akhtar MW, Okamoto S, Dziewczapolski G, Nakamura T, Cao G, Pratt AE, et al. Abeta induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss. Proc Natl Acad Sci U S A. 2013;110:E2518\u20132527.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"636_CR154","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3233\/JAD-160763","volume":"57","author":"R Wang","year":"2017","unstructured":"Wang R, Reddy PH. Role of glutamate and NMDA receptors in Alzheimer\u2019s Disease. J Alzheimers Dis. 2017;57:1041\u20138.","journal-title":"J Alzheimers Dis"},{"key":"636_CR155","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41591-019-0695-9","volume":"26","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Song WM, Andhey PS, Swain A, Levy T, Miller KR, Poliani PL, Cominelli M, Grover S, Gilfillan S, et al. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer\u2019s disease. Nat Med. 2020;26:131\u201342.","journal-title":"Nat Med"},{"key":"636_CR156","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41591-020-0815-6","volume":"26","author":"ECB Johnson","year":"2020","unstructured":"Johnson ECB, Dammer EB, Duong DM, Ping L, Zhou M, Yin L, Higginbotham LA, Guajardo A, White B, Troncoso JC, et al. Large-scale proteomic analysis of Alzheimer\u2019s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nat Med. 2020;26:769\u201380.","journal-title":"Nat Med"},{"key":"636_CR157","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1111\/j.1471-4159.2006.03935.x","volume":"98","author":"SL Kirvell","year":"2006","unstructured":"Kirvell SL, Esiri M, Francis PT. Down-regulation of vesicular glutamate transporters precedes cell loss and pathology in Alzheimer\u2019s disease. J Neurochem. 2006;98:939\u201350.","journal-title":"J Neurochem"},{"key":"636_CR158","doi-asserted-by":"publisher","first-page":"553e551","DOI":"10.1016\/j.neurobiolaging.2010.03.008","volume":"32","author":"HA Scott","year":"2011","unstructured":"Scott HA, Gebhardt FM, Mitrovic AD, Vandenberg RJ, Dodd PR. Glutamate transporter variants reduce glutamate uptake in Alzheimer\u2019s disease. Neurobiol Aging. 2011;32:553e551\u2013511.","journal-title":"Neurobiol Aging"},{"key":"636_CR159","doi-asserted-by":"publisher","first-page":"52","DOI":"10.2174\/1871527320666210212141232","volume":"21","author":"A Ludhiadch","year":"2022","unstructured":"Ludhiadch A, Sharma R, Muriki A, Munshi A. Role of Calcium Homeostasis in ischemic stroke: a review. CNS Neurol Disord Drug Targets. 2022;21:52\u201361.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"636_CR160","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/0166-2236(88)90200-7","volume":"11","author":"DW Choi","year":"1988","unstructured":"Choi DW. Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Neurosci. 1988;11:465\u20139.","journal-title":"Trends Neurosci"},{"key":"636_CR161","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/bpa.12425","volume":"27","author":"MQ Jiang","year":"2017","unstructured":"Jiang MQ, Zhao YY, Cao W, Wei ZZ, Gu X, Wei L, Yu SP. Long-term survival and regeneration of neuronal and vasculature cells inside the core region after ischemic stroke in adult mice. Brain Pathol. 2017;27:480\u201398.","journal-title":"Brain Pathol"},{"key":"636_CR162","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.brainres.2004.06.080","volume":"1022","author":"L Wei","year":"2004","unstructured":"Wei L, Ying DJ, Cui L, Langsdorf J, Yu S. Necrosis, apoptosis and hybrid death in the cortex and thalamus after barrel cortex ischemia in rats. Brain Res. 2004;1022:54\u201361.","journal-title":"Brain Res"},{"key":"636_CR163","doi-asserted-by":"publisher","first-page":"15927","DOI":"10.1523\/JNEUROSCI.3021-10.2010","volume":"30","author":"K Bordji","year":"2010","unstructured":"Bordji K, Becerril-Ortega J, Nicole O, Buisson A. Activation of extrasynaptic, but not synaptic, NMDA receptors modifies amyloid precursor protein expression pattern and increases amyloid-ss production. J Neurosci. 2010;30:15927\u201342.","journal-title":"J Neurosci"},{"key":"636_CR164","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1073\/pnas.0511065103","volume":"103","author":"G Amadoro","year":"2006","unstructured":"Amadoro G, Ciotti MT, Costanzi M, Cestari V, Calissano P, Canu N. NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK\/MAPK activation. Proc Natl Acad Sci U S A. 2006;103:2892\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"636_CR165","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuron.2010.01.008","volume":"65","author":"AJ Milnerwood","year":"2010","unstructured":"Milnerwood AJ, Gladding CM, Pouladi MA, Kaufman AM, Hines RM, Boyd JD, Ko RW, Vasuta OC, Graham RK, Hayden MR, et al. Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington\u2019s disease mice. Neuron. 2010;65:178\u201390.","journal-title":"Neuron"},{"key":"636_CR166","doi-asserted-by":"publisher","first-page":"641","DOI":"10.2165\/00023210-200317090-00004","volume":"17","author":"DA Butterfield","year":"2003","unstructured":"Butterfield DA, Pocernich CB. The glutamatergic system and Alzheimer\u2019s disease: therapeutic implications. CNS Drugs. 2003;17:641\u201352.","journal-title":"CNS Drugs"},{"key":"636_CR167","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1021\/acsbiomaterials.0c01583","volume":"7","author":"J Yin","year":"2021","unstructured":"Yin J, VanDongen AM. Enhanced neuronal activity and asynchronous calcium transients revealed in a 3D Organoid Model of Alzheimer\u2019s Disease. ACS Biomater Sci Eng. 2021;7:254\u201364.","journal-title":"ACS Biomater Sci Eng"},{"key":"636_CR168","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1177\/1073858407299730","volume":"13","author":"GE Stutzmann","year":"2007","unstructured":"Stutzmann GE. The pathogenesis of Alzheimers disease is it a lifelong \u201ccalciumopathy\u201d? Neuroscientist. 2007;13:546\u201359.","journal-title":"Neuroscientist"},{"key":"636_CR169","doi-asserted-by":"publisher","first-page":"8740","DOI":"10.1073\/pnas.1206171109","volume":"109","author":"MA Busche","year":"2012","unstructured":"Busche MA, Chen X, Henning HA, Reichwald J, Staufenbiel M, Sakmann B, Konnerth A. Critical role of soluble amyloid-beta for early hippocampal hyperactivity in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2012;109:8740\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"636_CR170","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1474-9726.2007.00289.x","volume":"6","author":"DL Dickstein","year":"2007","unstructured":"Dickstein DL, Kabaso D, Rocher AB, Luebke JI, Wearne SL, Hof PR. Changes in the structural complexity of the aged brain. Aging Cell. 2007;6:275\u201384.","journal-title":"Aging Cell"},{"key":"636_CR171","doi-asserted-by":"publisher","first-page":"5169","DOI":"10.2174\/1381612819666140110115603","volume":"20","author":"CH Lin","year":"2014","unstructured":"Lin CH, Huang YJ, Lin CJ, Lane HY, Tsai GE. NMDA neurotransmission dysfunction in mild cognitive impairment and Alzheimer\u2019s disease. Curr Pharm Des. 2014;20:5169\u201379.","journal-title":"Curr Pharm Des"},{"key":"636_CR172","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jalz.2019.07.017","volume":"16","author":"SL Angulo","year":"2020","unstructured":"Angulo SL, Henzi T, Neymotin SA, Suarez MD, Lytton WW, Schwaller B, Moreno H. Amyloid pathology-produced unexpected modifications of calcium homeostasis in hippocampal subicular dendrites. Alzheimers Dement. 2020;16:251\u201361.","journal-title":"Alzheimers Dement"},{"key":"636_CR173","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1111\/jnc.15323","volume":"157","author":"L Sosulina","year":"2021","unstructured":"Sosulina L, Mittag M, Geis HR, Hoffmann K, Klyubin I, Qi Y, Steffen J, Friedrichs D, Henneberg N, Fuhrmann F, et al. Hippocampal hyperactivity in a rat model of Alzheimer\u2019s disease. J Neurochem. 2021;157:2128\u201344.","journal-title":"J Neurochem"},{"key":"636_CR174","doi-asserted-by":"publisher","first-page":"595360","DOI":"10.3389\/fphar.2020.595360","volume":"11","author":"Y Wang","year":"2020","unstructured":"Wang Y, Shi Z, Zhang Y, Yan J, Yu W, Chen L. Oligomer beta-amyloid induces hyperactivation of ras to impede NMDA receptor-dependent long-term potentiation in hippocampal CA1 of mice. Front Pharmacol. 2020;11:595360.","journal-title":"Front Pharmacol"},{"key":"636_CR175","doi-asserted-by":"publisher","first-page":"600084","DOI":"10.3389\/fnmol.2020.600084","volume":"13","author":"A Hector","year":"2020","unstructured":"Hector A, Brouillette J. Hyperactivity Induced by Soluble amyloid-beta Oligomers in the early stages of Alzheimer\u2019s Disease. Front Mol Neurosci. 2020;13:600084.","journal-title":"Front Mol Neurosci"},{"key":"636_CR176","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1113\/jphysiol.2006.123570","volume":"580","author":"K Le Meur","year":"2007","unstructured":"Le Meur K, Galante M, Angulo MC, Audinat E. Tonic activation of NMDA receptors by ambient glutamate of non-synaptic origin in the rat hippocampus. J Physiol. 2007;580:373\u201383.","journal-title":"J Physiol"},{"key":"636_CR177","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1126\/science.2573153","volume":"246","author":"P Sah","year":"1989","unstructured":"Sah P, Hestrin S, Nicoll RA. Tonic activation of NMDA receptors by ambient glutamate enhances excitability of neurons. Science. 1989;246:815\u20138.","journal-title":"Science"},{"key":"636_CR178","doi-asserted-by":"publisher","first-page":"6920","DOI":"10.1523\/JNEUROSCI.0473-04.2004","volume":"24","author":"MC Angulo","year":"2004","unstructured":"Angulo MC, Kozlov AS, Charpak S, Audinat E. Glutamate released from glial cells synchronizes neuronal activity in the hippocampus. J Neurosci. 2004;24:6920\u20137.","journal-title":"J Neurosci"},{"key":"636_CR179","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainresbull.2014.12.007","volume":"112","author":"A Brassai","year":"2015","unstructured":"Brassai A, Suvanjeiev RG, Ban EG, Lakatos M. Role of synaptic and nonsynaptic glutamate receptors in ischaemia induced neurotoxicity. Brain Res Bull. 2015;112:1\u20136.","journal-title":"Brain Res Bull"},{"key":"636_CR180","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.brainresbull.2012.10.005","volume":"93","author":"ES Vizi","year":"2013","unstructured":"Vizi ES, Kisfali M, Lorincz T. Role of nonsynaptic GluN2B-containing NMDA receptors in excitotoxicity: evidence that fluoxetine selectively inhibits these receptors and may have neuroprotective effects. Brain Res Bull. 2013;93:32\u20138.","journal-title":"Brain Res Bull"},{"key":"636_CR181","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1152\/physrev.2001.81.3.1065","volume":"81","author":"GG Somjen","year":"2001","unstructured":"Somjen GG. Mechanisms of spreading depression and hypoxic spreading depression-like depolarization. Physiol Rev. 2001;81:1065\u201396.","journal-title":"Physiol Rev"},{"key":"636_CR182","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.bbabio.2008.04.017","volume":"1777","author":"AY Abramov","year":"2008","unstructured":"Abramov AY, Duchen MR. Mechanisms underlying the loss of mitochondrial membrane potential in glutamate excitotoxicity. Biochim Biophys Acta. 2008;1777:953\u201364.","journal-title":"Biochim Biophys Acta"},{"key":"636_CR183","doi-asserted-by":"publisher","first-page":"11246","DOI":"10.1523\/JNEUROSCI.2488-10.2010","volume":"30","author":"P Xia","year":"2010","unstructured":"Xia P, Chen HS, Zhang D, Lipton SA. Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses. J Neurosci. 2010;30:11246\u201350.","journal-title":"J Neurosci"},{"key":"636_CR184","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nrn2911","volume":"11","author":"GE Hardingham","year":"2010","unstructured":"Hardingham GE, Bading H. Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat Rev Neurosci. 2010;11:682\u201396.","journal-title":"Nat Rev Neurosci"},{"key":"636_CR185","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1007\/s10571-020-00924-0","volume":"41","author":"RG Mira","year":"2021","unstructured":"Mira RG, Cerpa W. Building a bridge between NMDAR-Mediated excitotoxicity and mitochondrial dysfunction in chronic and Acute Diseases. Cell Mol Neurobiol. 2021;41:1413\u201330.","journal-title":"Cell Mol Neurobiol"},{"key":"636_CR186","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.molmed.2010.12.008","volume":"17","author":"TW Lai","year":"2011","unstructured":"Lai TW, Shyu WC, Wang YT. Stroke intervention pathways: NMDA receptors and beyond. Trends Mol Med. 2011;17:266\u201375.","journal-title":"Trends Mol Med"},{"key":"636_CR187","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.neuron.2012.03.021","volume":"74","author":"MA Martel","year":"2012","unstructured":"Martel MA, Ryan TJ, Bell KF, Fowler JH, McMahon A, Al-Mubarak B, Komiyama NH, Horsburgh K, Kind PC, Grant SG, et al. The subtype of GluN2 C-terminal domain determines the response to excitotoxic insults. Neuron. 2012;74:543\u201356.","journal-title":"Neuron"},{"key":"636_CR188","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.cell.2013.02.002","volume":"152","author":"A Karpova","year":"2013","unstructured":"Karpova A, Mikhaylova M, Bera S, Bar J, Reddy PP, Behnisch T, Rankovic V, Spilker C, Bethge P, Sahin J, et al. Encoding and transducing the synaptic or extrasynaptic origin of NMDA receptor signals to the nucleus. Cell. 2013;152:1119\u201333.","journal-title":"Cell"},{"key":"636_CR189","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/85109","volume":"4","author":"GE Hardingham","year":"2001","unstructured":"Hardingham GE, Arnold FJ, Bading H. Nuclear calcium signaling controls CREB-mediated gene expression triggered by synaptic activity. Nat Neurosci. 2001;4:261\u20137.","journal-title":"Nat Neurosci"},{"key":"636_CR190","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1113\/jphysiol.2006.105510","volume":"572","author":"A Ivanov","year":"2006","unstructured":"Ivanov A, Pellegrino C, Rama S, Dumalska I, Salyha Y, Ben-Ari Y, Medina I. Opposing role of synaptic and extrasynaptic NMDA receptors in regulation of the extracellular signal-regulated kinases (ERK) activity in cultured rat hippocampal neurons. J Physiol. 2006;572:789\u201398.","journal-title":"J Physiol"},{"key":"636_CR191","doi-asserted-by":"publisher","first-page":"19354","DOI":"10.1074\/jbc.M110.127654","volume":"285","author":"O Dick","year":"2010","unstructured":"Dick O, Bading H. Synaptic activity and nuclear calcium signaling protect hippocampal neurons from death signal-associated nuclear translocation of FoxO3a induced by extrasynaptic N-methyl-D-aspartate receptors. J Biol Chem. 2010;285:19354\u201361.","journal-title":"J Biol Chem"},{"key":"636_CR192","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1046\/j.1471-4159.1999.0731075.x","volume":"73","author":"H Nakazawa","year":"1999","unstructured":"Nakazawa H, Murphy TH. Activation of nuclear calcium dynamics by synaptic stimulation in cultured cortical neurons. J Neurochem. 1999;73:1075\u201383.","journal-title":"J Neurochem"},{"key":"636_CR193","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1172\/JCI33144","volume":"120","author":"S Zheng","year":"2010","unstructured":"Zheng S, Eacker SM, Hong SJ, Gronostajski RM, Dawson TM, Dawson VL. NMDA-induced neuronal survival is mediated through nuclear factor I-A in mice. J Clin Invest. 2010;120:2446\u201356.","journal-title":"J Clin Invest"},{"key":"636_CR194","doi-asserted-by":"publisher","first-page":"787494","DOI":"10.3389\/fnsyn.2021.787494","volume":"13","author":"KM Grochowska","year":"2021","unstructured":"Grochowska KM, Bar J, Gomes GM, Kreutz MR, Karpova A. Jacob, a Synapto-Nuclear protein Messenger linking N-methyl-D-aspartate receptor activation to Nuclear Gene expression. Front Synaptic Neurosci. 2021;13:787494.","journal-title":"Front Synaptic Neurosci"},{"key":"636_CR195","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1371\/journal.pbio.0060034","volume":"6","author":"DC Dieterich","year":"2008","unstructured":"Dieterich DC, Karpova A, Mikhaylova M, Zdobnova I, Konig I, Landwehr M, Kreutz M, Smalla KH, Richter K, Landgraf P, et al. Caldendrin-Jacob: a protein liaison that couples NMDA receptor signalling to the nucleus. PLoS Biol. 2008;6:e34.","journal-title":"PLoS Biol"},{"key":"636_CR196","doi-asserted-by":"publisher","first-page":"105419","DOI":"10.1016\/j.nbd.2021.105419","volume":"156","author":"G Crivellaro","year":"2021","unstructured":"Crivellaro G, Tottene A, Vitale M, Melone M, Casari G, Conti F, Santello M, Pietrobon D. Specific activation of GluN1-N2B NMDA receptors underlies facilitation of cortical spreading depression in a genetic mouse model of migraine with reduced astrocytic glutamate clearance. Neurobiol Dis. 2021;156:105419.","journal-title":"Neurobiol Dis"},{"key":"636_CR197","doi-asserted-by":"publisher","first-page":"10963","DOI":"10.1523\/JNEUROSCI.3461-04.2004","volume":"24","author":"H Wang","year":"2004","unstructured":"Wang H, Yu SW, Koh DW, Lew J, Coombs C, Bowers W, Federoff HJ, Poirier GG, Dawson TM, Dawson VL. Apoptosis-inducing factor substitutes for caspase executioners in NMDA-triggered excitotoxic neuronal death. J Neurosci. 2004;24:10963\u201373.","journal-title":"J Neurosci"},{"key":"636_CR198","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/j.1471-4159.2012.07877.x","volume":"123","author":"PK Bahia","year":"2012","unstructured":"Bahia PK, Pugh V, Hoyland K, Hensley V, Rattray M, Williams RJ. Neuroprotective effects of phenolic antioxidant tBHQ associate with inhibition of FoxO3a nuclear translocation and activity. J Neurochem. 2012;123:182\u201391.","journal-title":"J Neurochem"},{"key":"636_CR199","doi-asserted-by":"publisher","first-page":"9330","DOI":"10.1523\/JNEUROSCI.2212-09.2009","volume":"29","author":"J Xu","year":"2009","unstructured":"Xu J, Kurup P, Zhang Y, Goebel-Goody SM, Wu PH, Hawasli AH, Baum ML, Bibb JA, Lombroso PJ. Extrasynaptic NMDA receptors couple preferentially to excitotoxicity via calpain-mediated cleavage of STEP. J Neurosci. 2009;29:9330\u201343.","journal-title":"J Neurosci"},{"key":"636_CR200","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/S1570-9639(02)00455-7","volume":"1600","author":"GE Hardingham","year":"2002","unstructured":"Hardingham GE, Bading H. Coupling of extrasynaptic NMDA receptors to a CREB shut-off pathway is developmentally regulated. Biochim Biophys Acta. 2002;1600:148\u201353.","journal-title":"Biochim Biophys Acta"},{"key":"636_CR201","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s00429-013-0539-1","volume":"219","author":"M Mikhaylova","year":"2014","unstructured":"Mikhaylova M, Karpova A, Bar J, Bethge P, YuanXiang P, Chen Y, Zuschratter W, Behnisch T, Kreutz MR. Cellular distribution of the NMDA-receptor activated synapto-nuclear messenger Jacob in the rat brain. Brain Struct Funct. 2014;219:843\u201360.","journal-title":"Brain Struct Funct"},{"key":"636_CR202","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.neurobiolaging.2014.09.006","volume":"36","author":"IL Ferreira","year":"2015","unstructured":"Ferreira IL, Ferreiro E, Schmidt J, Cardoso JM, Pereira CM, Carvalho AL, Oliveira CR, Rego AC. Abeta and NMDAR activation cause mitochondrial dysfunction involving ER calcium release. Neurobiol Aging. 2015;36:680\u201392.","journal-title":"Neurobiol Aging"},{"key":"636_CR203","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1073\/pnas.1321881111","volume":"111","author":"M Picard","year":"2014","unstructured":"Picard M, McEwen BS. Mitochondria impact brain function and cognition. Proc Natl Acad Sci U S A. 2014;111:7\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"636_CR204","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3233\/JAD-140972","volume":"43","author":"Y Wang","year":"2015","unstructured":"Wang Y, Wu L, Li J, Fang D, Zhong C, Chen JX, Yan SS. Synergistic exacerbation of mitochondrial and synaptic dysfunction and resultant learning and memory deficit in a mouse model of diabetic Alzheimer\u2019s disease. J Alzheimers Dis. 2015;43:451\u201363.","journal-title":"J Alzheimers Dis"},{"key":"636_CR205","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/nn2071","volume":"11","author":"S Papadia","year":"2008","unstructured":"Papadia S, Soriano FX, Leveille F, Martel MA, Dakin KA, Hansen HH, Kaindl A, Sifringer M, Fowler J, Stefovska V, et al. Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses. Nat Neurosci. 2008;11:476\u201387.","journal-title":"Nat Neurosci"},{"key":"636_CR206","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/0896-6273(88)90162-6","volume":"1","author":"DW Choi","year":"1988","unstructured":"Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1988;1:623\u201334.","journal-title":"Neuron"},{"key":"636_CR207","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1126\/science.284.5412.336","volume":"284","author":"SP Yu","year":"1999","unstructured":"Yu SP, Yeh C, Strasser U, Tian M, Choi DW. NMDA receptor-mediated K + efflux and neuronal apoptosis. Science. 1999;284:336\u20139.","journal-title":"Science"},{"key":"636_CR208","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12975-013-0314-x","volume":"5","author":"M Song","year":"2014","unstructured":"Song M, Yu SP. Ionic regulation of cell volume changes and cell death after ischemic stroke. Transl Stroke Res. 2014;5:17\u201327.","journal-title":"Transl Stroke Res"},{"key":"636_CR209","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.arcmed.2005.05.014","volume":"37","author":"A Camacho","year":"2006","unstructured":"Camacho A, Massieu L. Role of glutamate transporters in the clearance and release of glutamate during ischemia and its relation to neuronal death. Arch Med Res. 2006;37:11\u20138.","journal-title":"Arch Med Res"},{"key":"636_CR210","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/35002090","volume":"403","author":"DJ Rossi","year":"2000","unstructured":"Rossi DJ, Oshima T, Attwell D. Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature. 2000;403:316\u201321.","journal-title":"Nature"},{"key":"636_CR211","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0304-3940(93)90582-6","volume":"162","author":"S Rajdev","year":"1993","unstructured":"Rajdev S, Reynolds IJ. Calcium green-5\u00a0N, a novel fluorescent probe for monitoring high intracellular free Ca2 + concentrations associated with glutamate excitotoxicity in cultured rat brain neurons. Neurosci Lett. 1993;162:149\u201352.","journal-title":"Neurosci Lett"},{"key":"636_CR212","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1124\/mol.56.3.619","volume":"56","author":"L Kiedrowski","year":"1999","unstructured":"Kiedrowski L. N-methyl-D-aspartate excitotoxicity: relationships among plasma membrane potential, na(+)\/Ca(2+) exchange, mitochondrial ca(2+) overload, and cytoplasmic concentrations of ca(2+), H(+), and K(+). Mol Pharmacol. 1999;56:619\u201332.","journal-title":"Mol Pharmacol"},{"key":"636_CR213","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1523\/JNEUROSCI.08-01-00185.1988","volume":"8","author":"DW Choi","year":"1988","unstructured":"Choi DW, Koh JY, Peters S. Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists. J Neurosci. 1988;8:185\u201396.","journal-title":"J Neurosci"},{"key":"636_CR214","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1523\/JNEUROSCI.13-05-02085.1993","volume":"13","author":"M Tymianski","year":"1993","unstructured":"Tymianski M, Charlton MP, Carlen PL, Tator CH. Source specificity of early calcium neurotoxicity in cultured embryonic spinal neurons. J Neurosci. 1993;13:2085\u2013104.","journal-title":"J Neurosci"},{"key":"636_CR215","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1124\/jpet.105.094391","volume":"317","author":"L Wei","year":"2006","unstructured":"Wei L, Han BH, Li Y, Keogh CL, Holtzman DM, Yu SP. Cell death mechanism and protective effect of erythropoietin after focal ischemia in the whisker-barrel cortex of neonatal rats. J Pharmacol Exp Ther. 2006;317:109\u201316.","journal-title":"J Pharmacol Exp Ther"},{"key":"636_CR216","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1523\/JNEUROSCI.22-04-01350.2002","volume":"22","author":"AY Xiao","year":"2002","unstructured":"Xiao AY, Wei L, Xia S, Rothman S, Yu SP. Ionic mechanism of ouabain-induced concurrent apoptosis and necrosis in individual cultured cortical neurons. J Neurosci. 2002;22:1350\u201362.","journal-title":"J Neurosci"},{"key":"636_CR217","doi-asserted-by":"publisher","first-page":"42","DOI":"10.2174\/18715273113126660189","volume":"13","author":"SM Fayaz","year":"2014","unstructured":"Fayaz SM, Suvanish Kumar VS, Rajanikant GK. Necroptosis: who knew there were so many interesting ways to die? CNS Neurol Disord Drug Targets. 2014;13:42\u201351.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"636_CR218","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.2174\/1381612826666200113162641","volume":"26","author":"O Binvignat","year":"2020","unstructured":"Binvignat O, Olloquequi J. Excitotoxicity as a target against neurodegenerative processes. Curr Pharm Des. 2020;26:1251\u201362.","journal-title":"Curr Pharm Des"},{"key":"636_CR219","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.1994.tb44398.x","volume":"747","author":"ZS Khachaturian","year":"1994","unstructured":"Khachaturian ZS. Calcium hypothesis of Alzheimer\u2019s disease and brain aging. Ann N Y Acad Sci. 1994;747:1\u201311.","journal-title":"Ann N Y Acad Sci"},{"key":"636_CR220","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1126\/science.318.5849.384","volume":"318","author":"J Marx","year":"2007","unstructured":"Marx J. Alzheimer\u2019s disease. Fresh evidence points to an old suspect: calcium. Science. 2007;318:384\u20135.","journal-title":"Science"},{"key":"636_CR221","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1056\/NEJM199403033300907","volume":"330","author":"SA Lipton","year":"1994","unstructured":"Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med. 1994;330:613\u201322.","journal-title":"N Engl J Med"},{"key":"636_CR222","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jalz.2016.12.006","volume":"13","author":"Alzheimer\u2019s Association Calcium Hypothesis W","year":"2017","unstructured":"Alzheimer\u2019s Association Calcium Hypothesis W. Calcium hypothesis of Alzheimer\u2019s disease and brain aging: a framework for integrating new evidence into a comprehensive theory of pathogenesis. Alzheimers Dement. 2017;13:178\u2013182e117.","journal-title":"Alzheimers Dement"},{"key":"636_CR223","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40035-021-00260-3","volume":"10","author":"Y Bao","year":"2021","unstructured":"Bao Y, Yang X, Fu Y, Li Z, Gong R, Lu W. NMDAR-dependent somatic potentiation of synaptic inputs is correlated with beta amyloid-mediated neuronal hyperactivity. Transl Neurodegener. 2021;10:34.","journal-title":"Transl Neurodegener"},{"key":"636_CR224","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3233\/JAD-121990","volume":"35","author":"WY Ong","year":"2013","unstructured":"Ong WY, Tanaka K, Dawe GS, Ittner LM, Farooqui AA. Slow excitotoxicity in Alzheimer\u2019s disease. J Alzheimers Dis. 2013;35:643\u201368.","journal-title":"J Alzheimers Dis"},{"key":"636_CR225","first-page":"10603","volume":"426","author":"M Jiang","year":"2022","unstructured":"Jiang M, Fidler J, Berglund K, Gu X, Wu A, Estaba T, Patel J, Wei L, Yu SP. Delayed and brain region specific deletion of the NMDA receptor subunit GluN3A causes AD-like functional and behavioral changes in mice. Soc Neurosci 2022 Abstrct. 2022;426:10603.","journal-title":"Soc Neurosci 2022 Abstrct"},{"key":"636_CR226","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1016\/j.cellsig.2013.03.023","volume":"25","author":"F Simon","year":"2013","unstructured":"Simon F, Varela D, Cabello-Verrugio C. Oxidative stress-modulated TRPM ion channels in cell dysfunction and pathological conditions in humans. Cell Signal. 2013;25:1614\u201324.","journal-title":"Cell Signal"},{"key":"636_CR227","doi-asserted-by":"crossref","unstructured":"Vennekens R, Nilius B. Insights into TRPM4 function, regulation and physiological role. Handb Exp Pharmacol 2007:269\u201385.","DOI":"10.1007\/978-3-540-34891-7_16"},{"key":"636_CR228","doi-asserted-by":"crossref","unstructured":"Wang L, Fu TM, Zhou Y, Xia S, Greka A, Wu H. Structures and gating mechanism of human TRPM2. Science 2018, 362.","DOI":"10.1126\/science.aav4809"},{"key":"636_CR229","doi-asserted-by":"crossref","unstructured":"Yan J, Bengtson CP, Buchthal B, Hagenston AM, Bading H. Coupling of NMDA receptors and TRPM4 guides discovery of unconventional neuroprotectants. Science 2020, 370.","DOI":"10.1126\/science.aay3302"},{"key":"636_CR230","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1016\/j.neuron.2022.03.021","volume":"110","author":"P Zong","year":"2022","unstructured":"Zong P, Feng J, Yue Z, Li Y, Wu G, Sun B, He Y, Miller B, Yu AS, Su Z, et al. Functional coupling of TRPM2 and extrasynaptic NMDARs exacerbates excitotoxicity in ischemic brain injury. Neuron. 2022;110:1944\u201358. e1948.","journal-title":"Neuron"},{"key":"636_CR231","doi-asserted-by":"publisher","first-page":"148232","DOI":"10.1016\/j.brainres.2023.148232","volume":"1803","author":"K Yildizhan","year":"2023","unstructured":"Yildizhan K, Naziroglu M. NMDA receptor activation stimulates Hypoxia-Induced TRPM2 Channel activation, mitochondrial oxidative stress, and apoptosis in neuronal cell line: modular role of Memantine. Brain Res. 2023;1803:148232.","journal-title":"Brain Res"},{"key":"636_CR232","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.arr.2018.07.002","volume":"47","author":"LH Jiang","year":"2018","unstructured":"Jiang LH, Li X, Syed Mortadza SA, Lovatt M, Yang W. The TRPM2 channel nexus from oxidative damage to Alzheimer\u2019s pathologies: an emerging novel intervention target for age-related dementia. Ageing Res Rev. 2018;47:67\u201379.","journal-title":"Ageing Res Rev"},{"key":"636_CR233","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ceca.2011.11.008","volume":"51","author":"IL Ferreira","year":"2012","unstructured":"Ferreira IL, Bajouco LM, Mota SI, Auberson YP, Oliveira CR, Rego AC. Amyloid beta peptide 1\u201342 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical cultures. Cell Calcium. 2012;51:95\u2013106.","journal-title":"Cell Calcium"},{"key":"636_CR234","doi-asserted-by":"publisher","first-page":"11532","DOI":"10.1523\/JNEUROSCI.1603-16.2016","volume":"36","author":"BL Sinnen","year":"2016","unstructured":"Sinnen BL, Bowen AB, Gibson ES, Kennedy MJ. Local and Use-Dependent Effects of beta-amyloid oligomers on NMDA receptor function revealed by Optical Quantal Analysis. J Neurosci. 2016;36:11532\u201343.","journal-title":"J Neurosci"},{"key":"636_CR235","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.neures.2022.03.001","volume":"180","author":"K Taniguchi","year":"2022","unstructured":"Taniguchi K, Yamamoto F, Amamo A, Tamaoka A, Sanjo N, Yokota T, Kametani F, Araki W. Amyloid-beta oligomers interact with NMDA receptors containing GluN2B subunits and metabotropic glutamate receptor 1 in primary cortical neurons: relevance to the synapse pathology of Alzheimer\u2019s disease. Neurosci Res. 2022;180:90\u20138.","journal-title":"Neurosci Res"},{"key":"636_CR236","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.neurobiolaging.2021.05.006","volume":"105","author":"OJ Olajide","year":"2021","unstructured":"Olajide OJ, Chapman CA. Amyloid-beta (1\u201342) peptide induces rapid NMDA receptor-dependent alterations at glutamatergic synapses in the entorhinal cortex. Neurobiol Aging. 2021;105:296\u2013309.","journal-title":"Neurobiol Aging"},{"key":"636_CR237","doi-asserted-by":"publisher","first-page":"11590","DOI":"10.1074\/jbc.M607483200","volume":"282","author":"FG De Felice","year":"2007","unstructured":"De Felice FG, Velasco PT, Lambert MP, Viola K, Fernandez SJ, Ferreira ST, Klein WL. Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J Biol Chem. 2007;282:11590\u2013601.","journal-title":"J Biol Chem"},{"key":"636_CR238","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1523\/JNEUROSCI.3501-06.2007","volume":"27","author":"PN Lacor","year":"2007","unstructured":"Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, Wood M, Viola KL, Klein WL. Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer\u2019s disease. J Neurosci. 2007;27:796\u2013807.","journal-title":"J Neurosci"},{"key":"636_CR239","doi-asserted-by":"publisher","first-page":"11832","DOI":"10.1523\/JNEUROSCI.3478-07.2007","volume":"27","author":"DV Venkitaramani","year":"2007","unstructured":"Venkitaramani DV, Chin J, Netzer WJ, Gouras GK, Lesne S, Malinow R, Lombroso PJ. Beta-amyloid modulation of synaptic transmission and plasticity. J Neurosci. 2007;27:11832\u20137.","journal-title":"J Neurosci"},{"key":"636_CR240","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.conb.2011.09.001","volume":"22","author":"R Malinow","year":"2012","unstructured":"Malinow R. New developments on the role of NMDA receptors in Alzheimer\u2019s disease. Curr Opin Neurobiol. 2012;22:559\u201363.","journal-title":"Curr Opin Neurobiol"},{"key":"636_CR241","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3389\/fnins.2019.00043","volume":"13","author":"J Liu","year":"2019","unstructured":"Liu J, Chang L, Song Y, Li H, Wu Y. The role of NMDA receptors in Alzheimer\u2019s Disease. Front Neurosci. 2019;13:43.","journal-title":"Front Neurosci"},{"key":"636_CR242","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3233\/JAD-179941","volume":"64","author":"EN Cline","year":"2018","unstructured":"Cline EN, Bicca MA, Viola KL, Klein WL. The amyloid-beta oligomer hypothesis: beginning of the third decade. J Alzheimers Dis. 2018;64:567\u2013S610.","journal-title":"J Alzheimers Dis"},{"key":"636_CR243","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.expneurol.2007.10.008","volume":"210","author":"K Parameshwaran","year":"2008","unstructured":"Parameshwaran K, Dhanasekaran M, Suppiramaniam V. Amyloid beta peptides and glutamatergic synaptic dysregulation. Exp Neurol. 2008;210:7\u201313.","journal-title":"Exp Neurol"},{"key":"636_CR244","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ceca.2011.02.001","volume":"49","author":"L Texido","year":"2011","unstructured":"Texido L, Martin-Satue M, Alberdi E, Solsona C, Matute C. Amyloid beta peptide oligomers directly activate NMDA receptors. Cell Calcium. 2011;49:184\u201390.","journal-title":"Cell Calcium"},{"key":"636_CR245","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1038\/nn1503","volume":"8","author":"EM Snyder","year":"2005","unstructured":"Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EY, Nairn AC, Salter MW, Lombroso PJ, Gouras GK, Greengard P. Regulation of NMDA receptor trafficking by amyloid-beta. Nat Neurosci. 2005;8:1051\u20138.","journal-title":"Nat Neurosci"},{"key":"636_CR246","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/S0306-4522(99)00036-6","volume":"92","author":"M Noda","year":"1999","unstructured":"Noda M, Nakanishi H, Akaike N. Glutamate release from microglia via glutamate transporter is enhanced by amyloid-beta peptide. Neuroscience. 1999;92:1465\u201374.","journal-title":"Neuroscience"},{"key":"636_CR247","doi-asserted-by":"publisher","first-page":"131","DOI":"10.14336\/AD.2014.0423","volume":"6","author":"CC Rudy","year":"2015","unstructured":"Rudy CC, Hunsberger HC, Weitzner DS, Reed MN. The role of the tripartite glutamatergic synapse in the pathophysiology of Alzheimer\u2019s disease. Aging Dis. 2015;6:131\u201348.","journal-title":"Aging Dis"},{"key":"636_CR248","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s10072-016-2546-5","volume":"37","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Li P, Feng J, Wu M. Dysfunction of NMDA receptors in Alzheimer\u2019s disease. Neurol Sci. 2016;37:1039\u201347.","journal-title":"Neurol Sci"},{"key":"636_CR249","doi-asserted-by":"publisher","first-page":"418","DOI":"10.2174\/1567205016666190321163438","volume":"16","author":"L Pinheiro","year":"2019","unstructured":"Pinheiro L, Faustino C. Therapeutic strategies targeting amyloid-beta in Alzheimer\u2019s Disease. Curr Alzheimer Res. 2019;16:418\u201352.","journal-title":"Curr Alzheimer Res"},{"key":"636_CR250","doi-asserted-by":"publisher","first-page":"e2449","DOI":"10.1038\/cddis.2016.329","volume":"7","author":"XY Sun","year":"2016","unstructured":"Sun XY, Tuo QZ, Liuyang ZY, Xie AJ, Feng XL, Yan X, Qiu M, Li S, Wang XL, Cao FY, et al. Extrasynaptic NMDA receptor-induced tau overexpression mediates neuronal death through suppressing survival signaling ERK phosphorylation. Cell Death Dis. 2016;7:e2449.","journal-title":"Cell Death Dis"},{"key":"636_CR251","doi-asserted-by":"publisher","first-page":"e42318","DOI":"10.1371\/journal.pone.0042318","volume":"7","author":"Y Miao","year":"2012","unstructured":"Miao Y, Dong LD, Chen J, Hu XC, Yang XL, Wang Z. Involvement of calpain\/p35-p25\/Cdk5\/NMDAR signaling pathway in glutamate-induced neurotoxicity in cultured rat retinal neurons. PLoS ONE. 2012;7:e42318.","journal-title":"PLoS ONE"},{"key":"636_CR252","doi-asserted-by":"publisher","first-page":"6370","DOI":"10.1073\/pnas.1237107100","volume":"100","author":"M Hoshi","year":"2003","unstructured":"Hoshi M, Sato M, Matsumoto S, Noguchi A, Yasutake K, Yoshida N, Sato K. Spherical aggregates of beta-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I\/glycogen synthase kinase-3beta. Proc Natl Acad Sci U S A. 2003;100:6370\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"636_CR253","doi-asserted-by":"publisher","first-page":"e608","DOI":"10.1038\/cddis.2013.129","volume":"4","author":"C Tackenberg","year":"2013","unstructured":"Tackenberg C, Grinschgl S, Trutzel A, Santuccione AC, Frey MC, Konietzko U, Grimm J, Brandt R, Nitsch RM. NMDA receptor subunit composition determines beta-amyloid-induced neurodegeneration and synaptic loss. Cell Death Dis. 2013;4:e608.","journal-title":"Cell Death Dis"},{"key":"636_CR254","doi-asserted-by":"publisher","first-page":"9166","DOI":"10.1523\/JNEUROSCI.1074-10.2010","volume":"30","author":"H Decker","year":"2010","unstructured":"Decker H, Lo KY, Unger SM, Ferreira ST, Silverman MA. Amyloid-beta peptide oligomers disrupt axonal transport through an NMDA receptor-dependent mechanism that is mediated by glycogen synthase kinase 3beta in primary cultured hippocampal neurons. J Neurosci. 2010;30:9166\u201371.","journal-title":"J Neurosci"},{"key":"636_CR255","doi-asserted-by":"publisher","first-page":"9116","DOI":"10.1038\/s41598-019-45547-8","volume":"9","author":"N Pallas-Bazarra","year":"2019","unstructured":"Pallas-Bazarra N, Draffin J, Cuadros R, Antonio Esteban J, Avila J. Tau is required for the function of extrasynaptic NMDA receptors. Sci Rep. 2019;9:9116.","journal-title":"Sci Rep"},{"key":"636_CR256","doi-asserted-by":"publisher","first-page":"9367","DOI":"10.1523\/JNEUROSCI.0849-05.2005","volume":"25","author":"S Lesne","year":"2005","unstructured":"Lesne S, Ali C, Gabriel C, Croci N, MacKenzie ET, Glabe CG, Plotkine M, Marchand-Verrecchia C, Vivien D, Buisson A. NMDA receptor activation inhibits alpha-secretase and promotes neuronal amyloid-beta production. J Neurosci. 2005;25:9367\u201377.","journal-title":"J Neurosci"},{"key":"636_CR257","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.neuron.2005.10.028","volume":"48","author":"JR Cirrito","year":"2005","unstructured":"Cirrito JR, Yamada KA, Finn MB, Sloviter RS, Bales KR, May PC, Schoepp DD, Paul SM, Mennerick S, Holtzman DM. Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron. 2005;48:913\u201322.","journal-title":"Neuron"},{"key":"636_CR258","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1016\/j.neurobiolaging.2010.01.011","volume":"32","author":"R Ronicke","year":"2011","unstructured":"Ronicke R, Mikhaylova M, Ronicke S, Meinhardt J, Schroder UH, Fandrich M, Reiser G, Kreutz MR, Reymann KG. Early neuronal dysfunction by amyloid beta oligomers depends on activation of NR2B-containing NMDA receptors. Neurobiol Aging. 2011;32:2219\u201328.","journal-title":"Neurobiol Aging"},{"key":"636_CR259","doi-asserted-by":"publisher","first-page":"13594","DOI":"10.1073\/pnas.0901402106","volume":"106","author":"M Blurton-Jones","year":"2009","unstructured":"Blurton-Jones M, Kitazawa M, Martinez-Coria H, Castello NA, Muller FJ, Loring JF, Yamasaki TR, Poon WW, Green KN, LaFerla FM. Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc Natl Acad Sci U S A. 2009;106:13594\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"636_CR260","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41419-020-2615-9","volume":"11","author":"S Fernandez-Garcia","year":"2020","unstructured":"Fernandez-Garcia S, Sancho-Balsells A, Longueville S, Herve D, Gruart A, Delgado-Garcia JM, Alberch J, Giralt A. Astrocytic BDNF and TrkB regulate severity and neuronal activity in mouse models of temporal lobe epilepsy. Cell Death Dis. 2020;11:411.","journal-title":"Cell Death Dis"},{"key":"636_CR261","doi-asserted-by":"publisher","first-page":"22687","DOI":"10.1073\/pnas.1012851108","volume":"107","author":"A Caccamo","year":"2010","unstructured":"Caccamo A, Maldonado MA, Bokov AF, Majumder S, Oddo S. CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2010;107:22687\u201392.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"636_CR262","doi-asserted-by":"publisher","first-page":"4442","DOI":"10.1523\/JNEUROSCI.6017-08.2009","volume":"29","author":"SE Hoey","year":"2009","unstructured":"Hoey SE, Williams RJ, Perkinton MS. Synaptic NMDA receptor activation stimulates alpha-secretase amyloid precursor protein processing and inhibits amyloid-beta production. J Neurosci. 2009;29:4442\u201360.","journal-title":"J Neurosci"},{"key":"636_CR263","doi-asserted-by":"publisher","first-page":"787","DOI":"10.2174\/156802606777057553","volume":"6","author":"M Hetman","year":"2006","unstructured":"Hetman M, Kharebava G. Survival signaling pathways activated by NMDA receptors. Curr Top Med Chem. 2006;6:787\u201399.","journal-title":"Curr Top Med Chem"},{"key":"636_CR264","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","volume":"148","author":"DC Javitt","year":"1991","unstructured":"Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry. 1991;148:1301\u20138.","journal-title":"Am J Psychiatry"},{"key":"636_CR265","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","volume":"51","author":"JH Krystal","year":"1994","unstructured":"Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB Jr, Charney DS. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry. 1994;51:199\u2013214.","journal-title":"Arch Gen Psychiatry"},{"key":"636_CR266","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1097\/00001756-199504190-00011","volume":"6","author":"AC Lahti","year":"1995","unstructured":"Lahti AC, Holcomb HH, Medoff DR, Tamminga CA. Ketamine activates psychosis and alters limbic blood flow in schizophrenia. NeuroReport. 1995;6:869\u201372.","journal-title":"NeuroReport"},{"key":"636_CR267","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0028-3908(99)00019-2","volume":"38","author":"CG Parsons","year":"1999","unstructured":"Parsons CG, Danysz W, Quack G. Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist\u2013a review of preclinical data. Neuropharmacology. 1999;38:735\u201367.","journal-title":"Neuropharmacology"},{"key":"636_CR268","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/nrd1958","volume":"5","author":"SA Lipton","year":"2006","unstructured":"Lipton SA. Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond. Nat Rev Drug Discov. 2006;5:160\u201370.","journal-title":"Nat Rev Drug Discov"},{"key":"636_CR269","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2015.01.041","volume":"1603","author":"YN Wu","year":"2015","unstructured":"Wu YN, Johnson SW. Memantine selectively blocks extrasynaptic NMDA receptors in rat substantia nigra dopamine neurons. Brain Res. 2015;1603:1\u20137.","journal-title":"Brain Res"},{"key":"636_CR270","first-page":"113","volume":"13","author":"MU Aluclu","year":"2008","unstructured":"Aluclu MU, Arslan S, Acar A, Guzel A, Bahceci S, Yaldiz M. Evaluation of effects of memantine on cerebral ischemia in rats. Neurosciences (Riyadh). 2008;13:113\u20136. PMID: 21063302.","journal-title":"Neurosciences (Riyadh)"},{"key":"636_CR271","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0014-2999(90)90206-L","volume":"185","author":"M Seif el Nasr","year":"1990","unstructured":"Seif el Nasr M, Peruche B, Rossberg C, Mennel HD, Krieglstein J. Neuroprotective effect of memantine demonstrated in vivo and in vitro. Eur J Pharmacol. 1990;185:19\u201324.","journal-title":"Eur J Pharmacol"},{"key":"636_CR272","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.neuroscience.2013.01.059","volume":"237","author":"U Kilic","year":"2013","unstructured":"Kilic U, Yilmaz B, Reiter RJ, Yuksel A, Kilic E. Effects of memantine and melatonin on signal transduction pathways vascular leakage and brain injury after focal cerebral ischemia in mice. Neuroscience. 2013;237:268\u201376.","journal-title":"Neuroscience"},{"key":"636_CR273","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.yexcr.2016.12.028","volume":"351","author":"B Chen","year":"2017","unstructured":"Chen B, Wang G, Li W, Liu W, Lin R, Tao J, Jiang M, Chen L, Wang Y. Memantine attenuates cell apoptosis by suppressing the calpain-caspase-3 pathway in an experimental model of ischemic stroke. Exp Cell Res. 2017;351:163\u201372.","journal-title":"Exp Cell Res"},{"key":"636_CR274","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1161\/01.STR.0000125855.17686.6d","volume":"35","author":"C Culmsee","year":"2004","unstructured":"Culmsee C, Junker V, Kremers W, Thal S, Plesnila N, Krieglstein J. Combination therapy in ischemic stroke: synergistic neuroprotective effects of memantine and clenbuterol. Stroke. 2004;35:1197\u2013202.","journal-title":"Stroke"},{"key":"636_CR275","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/jcbfm.2014.188","volume":"35","author":"M Trotman","year":"2015","unstructured":"Trotman M, Vermehren P, Gibson CL, Fern R. The dichotomy of memantine treatment for ischemic stroke: dose-dependent protective and detrimental effects. J Cereb Blood Flow Metab. 2015;35:230\u20139.","journal-title":"J Cereb Blood Flow Metab"},{"key":"636_CR276","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.brainres.2006.02.093","volume":"1088","author":"PA Lapchak","year":"2006","unstructured":"Lapchak PA. Memantine, an uncompetitive low affinity NMDA open-channel antagonist improves clinical rating scores in a multiple infarct embolic stroke model in rabbits. Brain Res. 2006;1088:141\u20137.","journal-title":"Brain Res"},{"key":"636_CR277","doi-asserted-by":"publisher","first-page":"RRN1291","DOI":"10.1371\/currents.RRN1291","volume":"3","author":"MG Beconi","year":"2011","unstructured":"Beconi MG, Howland D, Park L, Lyons K, Giuliano J, Dominguez C, Munoz-Sanjuan I, Pacifici R. Pharmacokinetics of memantine in rats and mice. PLoS Curr. 2011;3:RRN1291.","journal-title":"PLoS Curr"},{"key":"636_CR278","doi-asserted-by":"publisher","first-page":"870","DOI":"10.2353\/ajpath.2010.090452","volume":"176","author":"H Martinez-Coria","year":"2010","unstructured":"Martinez-Coria H, Green KN, Billings LM, Kitazawa M, Albrecht M, Rammes G, Parsons CG, Gupta S, Banerjee P, LaFerla FM. Memantine improves cognition and reduces Alzheimer\u2019s-like neuropathology in transgenic mice. Am J Pathol. 2010;176:870\u201380.","journal-title":"Am J Pathol"},{"key":"636_CR279","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1161\/STROKEAHA.113.004476","volume":"45","author":"HE Lopez-Valdes","year":"2014","unstructured":"Lopez-Valdes HE, Clarkson AN, Ao Y, Charles AC, Carmichael ST, Sofroniew MV, Brennan KC. Memantine enhances recovery from stroke. Stroke. 2014;45:2093\u2013100.","journal-title":"Stroke"},{"key":"636_CR280","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s12035-020-02120-z","volume":"58","author":"M Stazi","year":"2021","unstructured":"Stazi M, Wirths O. Chronic Memantine Treatment ameliorates behavioral deficits, neuron loss, and impaired neurogenesis in a model of Alzheimer\u2019s Disease. Mol Neurobiol. 2021;58:204\u201316.","journal-title":"Mol Neurobiol"},{"key":"636_CR281","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.mcna.2018.10.009","volume":"103","author":"A Atri","year":"2019","unstructured":"Atri A. The Alzheimer\u2019s Disease Clinical Spectrum: diagnosis and management. Med Clin North Am. 2019;103:263\u201393.","journal-title":"Med Clin North Am"},{"key":"636_CR282","doi-asserted-by":"publisher","first-page":"805","DOI":"10.4103\/1673-5374.249228","volume":"14","author":"BR Jin","year":"2019","unstructured":"Jin BR, Liu HY. Comparative efficacy and safety of cognitive enhancers for treating vascular cognitive impairment: systematic review and bayesian network meta-analysis. Neural Regen Res. 2019;14:805\u201316.","journal-title":"Neural Regen Res"},{"key":"636_CR283","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/jgs.15069","volume":"66","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Ashoor HM, Soobiah C, Rios P, Veroniki AA, Hamid JS, Ivory JD, Khan PA, Yazdi F, Ghassemi M, et al. Comparative effectiveness and safety of cognitive enhancers for treating Alzheimer\u2019s Disease: systematic review and network metaanalysis. J Am Geriatr Soc. 2018;66:170\u20138.","journal-title":"J Am Geriatr Soc"},{"key":"636_CR284","doi-asserted-by":"publisher","first-page":"577","DOI":"10.2165\/00002018-200831070-00003","volume":"31","author":"MR Farlow","year":"2008","unstructured":"Farlow MR, Graham SM, Alva G. Memantine for the treatment of Alzheimer\u2019s disease: tolerability and safety data from clinical trials. Drug Saf. 2008;31:577\u201385.","journal-title":"Drug Saf"},{"key":"636_CR285","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/00004850-200211000-00005","volume":"17","author":"G Wilcock","year":"2002","unstructured":"Wilcock G, Mobius HJ, group Stoffler A. A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500). Int Clin Psychopharmacol. 2002;17:297\u2013305.","journal-title":"Int Clin Psychopharmacol"},{"key":"636_CR286","doi-asserted-by":"publisher","first-page":"4427","DOI":"10.1523\/JNEUROSCI.12-11-04427.1992","volume":"12","author":"HS Chen","year":"1992","unstructured":"Chen HS, Pellegrini JW, Aggarwal SK, Lei SZ, Warach S, Jensen FE, Lipton SA. Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity. J Neurosci. 1992;12:4427\u201336.","journal-title":"J Neurosci"},{"key":"636_CR287","first-page":"29763201","volume-title":"StatPearls [Internet]","author":"B Kuns","year":"2022","unstructured":"Kuns B, Rosani A. D. V: Mematine. In StatPearls [Internet]. Volume Jan-. FL: StatPearls Publishing; 2022: 29763201."},{"key":"636_CR288","first-page":"773","volume":"41","author":"K Ditzler","year":"1991","unstructured":"Ditzler K. Efficacy and tolerability of memantine in patients with dementia syndrome. A double-blind, placebo controlled trial. Arzneimittelforschung. 1991;41:773\u201380. PMID: 1781796.","journal-title":"Arzneimittelforschung"},{"key":"636_CR289","doi-asserted-by":"publisher","first-page":"e0123289","DOI":"10.1371\/journal.pone.0123289","volume":"10","author":"S Matsunaga","year":"2015","unstructured":"Matsunaga S, Kishi T, Iwata N. Memantine monotherapy for Alzheimer\u2019s disease: a systematic review and meta-analysis. PLoS ONE. 2015;10:e0123289.","journal-title":"PLoS ONE"},{"key":"636_CR290","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3233\/JAD-170672","volume":"62","author":"J Folch","year":"2018","unstructured":"Folch J, Busquets O, Ettcheto M, Sanchez-Lopez E, Castro-Torres RD, Verdaguer E, Garcia ML, Olloquequi J, Casadesus G, Beas-Zarate C, et al. Memantine for the treatment of dementia: a review on its current and future applications. J Alzheimers Dis. 2018;62:1223\u201340.","journal-title":"J Alzheimers Dis"},{"key":"636_CR291","first-page":"338","volume":"9","author":"B Souchet","year":"2022","unstructured":"Souchet B, Audrain M, Alves S, Fol R, Tada S, Orefice NS, Potier B, Dutar P, Billard JM, Cartier N, Braudeau J. Evaluation of Memantine in AAV-AD Rat: a model of late-onset Alzheimer\u2019s Disease Predementia. J Prev Alzheimers Dis. 2022;9:338\u201347. PMID: 35543008.","journal-title":"J Prev Alzheimers Dis"},{"key":"636_CR292","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1001\/jama.1997.03540340066035","volume":"277","author":"SG Post","year":"1997","unstructured":"Post SG, Whitehouse PJ, Binstock RH, Bird TD, Eckert SK, Farrer LA, Fleck LM, Gaines AD, Juengst ET, Karlinsky H, et al. The clinical introduction of genetic testing for Alzheimer disease. An ethical perspective. JAMA. 1997;277:832\u20136.","journal-title":"JAMA"},{"key":"636_CR293","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s13311-021-01152-0","volume":"19","author":"MI Kamboh","year":"2022","unstructured":"Kamboh MI. Genomics and Functional Genomics of Alzheimer\u2019s Disease. Neurotherapeutics. 2022;19:152\u201372.","journal-title":"Neurotherapeutics"},{"key":"636_CR294","first-page":"R235","volume":"28","author":"J Hardy","year":"2019","unstructured":"Hardy J, Escott-Price V. Genes, pathways and risk prediction in Alzheimer\u2019s disease. Hum Mol Genet. 2019;28:R235\u201340.","journal-title":"Hum Mol Genet"},{"key":"636_CR295","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41588-018-0058-3","volume":"50","author":"R Malik","year":"2018","unstructured":"Malik R, Chauhan G, Traylor M, Sargurupremraj M, Okada Y, Mishra A, Rutten-Jacobs L, Giese AK, van der Laan SW, Gretarsdottir S, et al. Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat Genet. 2018;50:524\u201337.","journal-title":"Nat Genet"},{"key":"636_CR296","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1136\/jnnp.2007.141648","volume":"79","author":"R Schmidt","year":"2008","unstructured":"Schmidt R, Ropele S, Pendl B, Ofner P, Enzinger C, Schmidt H, Berghold A, Windisch M, Kolassa H, Fazekas F. Longitudinal multimodal imaging in mild to moderate Alzheimer disease: a pilot study with memantine. J Neurol Neurosurg Psychiatry. 2008;79:1312\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Suppl 1","key":"636_CR297","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1017\/S1041610203009219","volume":"15","author":"HJ Mobius","year":"2003","unstructured":"Mobius HJ, Stoffler A. Memantine in vascular dementia. Int Psychogeriatr. 2003;15(Suppl 1):207\u201313.","journal-title":"Int Psychogeriatr"},{"key":"636_CR298","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1159\/000430808","volume":"40","author":"N Zhang","year":"2015","unstructured":"Zhang N, Wei C, Du H, Shi FD, Cheng Y. The Effect of Memantine on cognitive function and behavioral and psychological symptoms in mild-to-moderate Alzheimer\u2019s Disease Patients. Dement Geriatr Cogn Disord. 2015;40:85\u201393.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"636_CR299","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/WAD.0b013e318032cf29","volume":"21","author":"N Pomara","year":"2007","unstructured":"Pomara N, Ott BR, Peskind E, Resnick EM. Memantine treatment of cognitive symptoms in mild to moderate Alzheimer disease: secondary analyses from a placebo-controlled randomized trial. Alzheimer Dis Assoc Disord. 2007;21:60\u20134.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"636_CR300","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1161\/01.STR.0000020094.08790.49","volume":"33","author":"JM Orgogozo","year":"2002","unstructured":"Orgogozo JM, Rigaud AS, Stoffler A, Mobius HJ, Forette F. Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300). Stroke. 2002;33:1834\u20139.","journal-title":"Stroke"},{"key":"636_CR301","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1177\/0300060517715166","volume":"45","author":"D Ilhan Algin","year":"2017","unstructured":"Ilhan Algin D, Dagli Atalay S, Ozkan S, Ozbabalik Adapinar D, Ak Sivrioz I. Memantine improves semantic memory in patients with amnestic mild cognitive impairment: a single-photon emission computed tomography study. J Int Med Res. 2017;45:2053\u201364.","journal-title":"J Int Med Res"},{"key":"636_CR302","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3233\/JAD-2007-11409","volume":"11","author":"S Bakchine","year":"2007","unstructured":"Bakchine S, Loft H. Memantine treatment in patients with mild to moderate Alzheimer\u2019s disease: results of a randomised, double-blind, placebo-controlled 6-month study. J Alzheimers Dis. 2007;11:471\u20139.","journal-title":"J Alzheimers Dis"},{"key":"636_CR303","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1212\/WNL.0b013e3181eb5872","volume":"75","author":"JS Roberts","year":"2010","unstructured":"Roberts JS, Karlawish JH, Uhlmann WR, Petersen RC, Green RC. Mild cognitive impairment in clinical care: a survey of American Academy of Neurology members. Neurology. 2010;75:425\u201331.","journal-title":"Neurology"},{"key":"636_CR304","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1001\/archneurol.2011.69","volume":"68","author":"LS Schneider","year":"2011","unstructured":"Schneider LS, Dagerman KS, Higgins JP, McShane R. Lack of evidence for the efficacy of memantine in mild Alzheimer disease. Arch Neurol. 2011;68:991\u20138.","journal-title":"Arch Neurol"},{"key":"636_CR305","doi-asserted-by":"crossref","unstructured":"Pribish A, Wood N, Kalava A. A Review of Nonanesthetic Uses of Ketamine. Anesthesiol Res Pract 2020, 2020:5798285.","DOI":"10.1155\/2020\/5798285"},{"key":"636_CR306","doi-asserted-by":"publisher","first-page":"6431","DOI":"10.1038\/s41467-020-20190-4","volume":"11","author":"ED Ballard","year":"2020","unstructured":"Ballard ED, Zarate CA Jr. The role of dissociation in ketamine\u2019s antidepressant effects. Nat Commun. 2020;11:6431.","journal-title":"Nat Commun"},{"key":"636_CR307","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","volume":"47","author":"RM Berman","year":"2000","unstructured":"Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, Krystal JH. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry. 2000;47:351\u20134.","journal-title":"Biol Psychiatry"},{"key":"636_CR308","doi-asserted-by":"publisher","first-page":"672526","DOI":"10.3389\/fnins.2021.672526","volume":"15","author":"D Choudhury","year":"2021","unstructured":"Choudhury D, Autry AE, Tolias KF, Krishnan V. Ketamine: neuroprotective or neurotoxic? Front Neurosci. 2021;15:672526.","journal-title":"Front Neurosci"},{"key":"636_CR309","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1080\/14656566.2018.1471136","volume":"19","author":"M Lozupone","year":"2018","unstructured":"Lozupone M, La Montagna M, D\u2019Urso F, Piccininni C, Sardone R, Dibello V, Giannelli G, Solfrizzi V, Greco A, Daniele A, et al. Pharmacotherapy for the treatment of depression in patients with alzheimer\u2019s disease: a treatment-resistant depressive disorder. Expert Opin Pharmacother. 2018;19:823\u201342.","journal-title":"Expert Opin Pharmacother"},{"key":"636_CR310","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/HRP.0000000000000312","volume":"29","author":"B Souza-Marques","year":"2021","unstructured":"Souza-Marques B, Santos-Lima C, Araujo-de-Freitas L, Vieira F, Jesus-Nunes AP, Quarantini LC, Sampaio AS. Neurocognitive Effects of ketamine and esketamine for treatment-resistant major depressive disorder: a systematic review. Harv Rev Psychiatry. 2021;29:340\u201350.","journal-title":"Harv Rev Psychiatry"},{"key":"636_CR311","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jad.2018.12.005","volume":"246","author":"W Zheng","year":"2019","unstructured":"Zheng W, Zhou YL, Liu WJ, Wang CY, Zhan YN, Li HQ, Chen LJ, Li MD, Ning YP. Neurocognitive performance and repeated-dose intravenous ketamine in major depressive disorder. J Affect Disord. 2019;246:241\u20137.","journal-title":"J Affect Disord"},{"key":"636_CR312","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/bs.apha.2020.02.005","volume":"89","author":"SZ Iqbal","year":"2020","unstructured":"Iqbal SZ, Mathew SJ. Ketamine for depression clinical issues. Adv Pharmacol. 2020;89:131\u201362.","journal-title":"Adv Pharmacol"},{"key":"636_CR313","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13041-018-0357-8","volume":"11","author":"QJ Wu","year":"2018","unstructured":"Wu QJ, Tymianski M. Targeting NMDA receptors in stroke: new hope in neuroprotection. Mol Brain. 2018;11:15.","journal-title":"Mol Brain"},{"key":"636_CR314","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.pneurobio.2017.01.001","volume":"157","author":"S Li","year":"2017","unstructured":"Li S, Hafeez A, Noorulla F, Geng X, Shao G, Ren C, Lu G, Zhao H, Ding Y, Ji X. Preconditioning in neuroprotection: from hypoxia to ischemia. Prog Neurobiol. 2017;157:79\u201391.","journal-title":"Prog Neurobiol"},{"key":"636_CR315","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1161\/STROKEAHA.114.002879","volume":"45","author":"SL Stevens","year":"2014","unstructured":"Stevens SL, Vartanian KB, Stenzel-Poore MP. Reprogramming the response to stroke by preconditioning. Stroke. 2014;45:2527\u201331.","journal-title":"Stroke"},{"key":"636_CR316","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4103\/bc.bc_31_19","volume":"5","author":"B Gonzales-Portillo","year":"2019","unstructured":"Gonzales-Portillo B, Lippert T, Nguyen H, Lee JY, Borlongan CV. Hyperbaric oxygen therapy: a new look on treating stroke and traumatic brain injury. Brain Circ. 2019;5:101\u20135.","journal-title":"Brain Circ"},{"key":"636_CR317","unstructured":"Gu X, Jiang MQ, Lin T, Shah N, Wei L, Yu SP. Preventive memantine treatment for the comorbidity of stroke and Alzheimer\u2019s disease. Annual Meeting of Society for Neuroscience 2022, 10922:2022-S-10922-SfN."},{"key":"636_CR318","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2174\/156720506777632808","volume":"3","author":"Y Wang","year":"2006","unstructured":"Wang Y, Eu J, Washburn M, Gong T, Chen HS, James WL, Lipton SA, Stamler JS, Went GT, Porter S. The pharmacology of aminoadamantane nitrates. Curr Alzheimer Res. 2006;3:201\u20134.","journal-title":"Curr Alzheimer Res"},{"key":"636_CR319","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.biopsych.2021.04.024","volume":"90","author":"BK Chen","year":"2021","unstructured":"Chen BK, Luna VM, Shannon ME, Hunsberger HC, Mastrodonato A, Stackmann M, McGowan JC, Rubinstenn G, Denny CA. Fluoroethylnormemantine, a novel NMDA receptor antagonist, for the Prevention and treatment of Stress-Induced Maladaptive Behavior. Biol Psychiatry. 2021;90:458\u201372.","journal-title":"Biol Psychiatry"},{"key":"636_CR320","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/ijnp\/pyab007","volume":"24","author":"BK Chen","year":"2021","unstructured":"Chen BK, Le Pen G, Eckmier A, Rubinstenn G, Jay TM, Denny CA. Fluoroethylnormemantine, a Novel Derivative of Memantine, facilitates extinction learning without Sensorimotor deficits. Int J Neuropsychopharmacol. 2021;24:519\u201331.","journal-title":"Int J Neuropsychopharmacol"},{"key":"636_CR321","doi-asserted-by":"publisher","first-page":"e13371","DOI":"10.1111\/acel.13371","volume":"20","author":"L Wu","year":"2021","unstructured":"Wu L, Zhou X, Cao Y, Mak SH, Zha L, Li N, Su Z, Han Y, Wang Y, Man Hoi MP, et al. Therapeutic efficacy of novel memantine nitrate MN-08 in animal models of Alzheimer\u2019s disease. Aging Cell. 2021;20:e13371.","journal-title":"Aging Cell"},{"key":"636_CR322","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1523\/JNEUROSCI.1871-20.2020","volume":"41","author":"D Trudler","year":"2021","unstructured":"Trudler D, Sanz-Blasco S, Eisele YS, Ghatak S, Bodhinathan K, Akhtar MW, Lynch WP, Pina-Crespo JC, Talantova M, Kelly JW. Lipton SA: alpha-synuclein oligomers induce glutamate release from astrocytes and excessive extrasynaptic NMDAR activity in neurons, thus contributing to synapse loss. J Neurosci. 2021;41:2264\u201373.","journal-title":"J Neurosci"},{"key":"636_CR323","doi-asserted-by":"publisher","first-page":"5751","DOI":"10.1038\/s41380-020-0776-7","volume":"26","author":"S Ghatak","year":"2021","unstructured":"Ghatak S, Dolatabadi N, Gao R, Wu Y, Scott H, Trudler D, Sultan A, Ambasudhan R, Nakamura T, Masliah E, et al. NitroSynapsin ameliorates hypersynchronous neural network activity in Alzheimer hiPSC models. Mol Psychiatry. 2021;26:5751\u201365.","journal-title":"Mol Psychiatry"},{"key":"636_CR324","doi-asserted-by":"publisher","first-page":"5495","DOI":"10.1021\/acs.nanolett.6b01988","volume":"16","author":"A Savchenko","year":"2016","unstructured":"Savchenko A, Braun GB, Molokanova E. Nanostructured antagonist of extrasynaptic NMDA receptors. Nano Lett. 2016;16:5495\u2013502.","journal-title":"Nano Lett"},{"key":"636_CR325","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.pbb.2006.08.011","volume":"85","author":"PR Zoladz","year":"2006","unstructured":"Zoladz PR, Campbell AM, Park CR, Schaefer D, Danysz W, Diamond DM. Enhancement of long-term spatial memory in adult rats by the noncompetitive NMDA receptor antagonists, memantine and neramexane. Pharmacol Biochem Behav. 2006;85:298\u2013306.","journal-title":"Pharmacol Biochem Behav"},{"key":"636_CR326","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1586\/ecp.09.7","volume":"2","author":"G Rammes","year":"2009","unstructured":"Rammes G. Neramexane: a moderate-affinity NMDA receptor channel blocker: new prospects and indications. Expert Rev Clin Pharmacol. 2009;2:231\u20138.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"636_CR327","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6815-11-1","volume":"11","author":"M Suckfull","year":"2011","unstructured":"Suckfull M, Althaus M, Ellers-Lenz B, Gebauer A, Gortelmeyer R, Jastreboff PJ, Moebius HJ, Rosenberg T, Russ H, Wirth Y, Krueger H. A randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of neramexane in patients with moderate to severe subjective tinnitus. BMC Ear Nose Throat Disord. 2011;11:1.","journal-title":"BMC Ear Nose Throat Disord"},{"key":"636_CR328","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s11011-013-9424-0","volume":"28","author":"J Zhang","year":"2013","unstructured":"Zhang J, Wang C, Deng T, Xue Z, Chen X, Chang L, Wang Q. The preventive effect of NR2B and NR2D-containing NMDAR antagonists on Abeta-induced LTP disruption in the dentate gyrus of rats. Metab Brain Dis. 2013;28:697\u2013704.","journal-title":"Metab Brain Dis"},{"key":"636_CR329","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1124\/mol.111.073239","volume":"80","author":"TM Acker","year":"2011","unstructured":"Acker TM, Yuan H, Hansen KB, Vance KM, Ogden KK, Jensen HS, Burger PB, Mullasseril P, Snyder JP, Liotta DC, Traynelis SF. Mechanism for noncompetitive inhibition by novel GluN2C\/D N-methyl-D-aspartate receptor subunit-selective modulators. Mol Pharmacol. 2011;80:782\u201395.","journal-title":"Mol Pharmacol"},{"key":"636_CR330","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X20666220302151224","author":"SI Hamstra","year":"2022","unstructured":"Hamstra SI, Roy BD, Tiidus P, MacNeil AJ, Klentrou P, MacPherson REK, Fajardo VA. Beyond its psychiatric use: the benefits of low dose lithium supplementation. Curr Neuropharmacol. 2022. https:\/\/doi.org\/10.2174\/1570159X20666220302151224. Online ahead of print:.","journal-title":"Curr Neuropharmacol"},{"key":"636_CR331","doi-asserted-by":"publisher","first-page":"136044","DOI":"10.1016\/j.neulet.2021.136044","volume":"760","author":"R Haussmann","year":"2021","unstructured":"Haussmann R, Noppes F, Brandt MD, Bauer M, Donix M. Lithium: a therapeutic option in Alzheimer\u2019s disease and its prodromal stages? Neurosci Lett. 2021;760:136044.","journal-title":"Neurosci Lett"},{"key":"636_CR332","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1038\/sj.npp.1300920","volume":"31","author":"M Basselin","year":"2006","unstructured":"Basselin M, Chang L, Bell JM, Rapoport SI. Chronic lithium chloride administration attenuates brain NMDA receptor-initiated signaling via arachidonic acid in unanesthetized rats. Neuropsychopharmacology. 2006;31:1659\u201374.","journal-title":"Neuropsychopharmacology"},{"key":"636_CR333","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fncel.2018.00016","volume":"12","author":"SA Monaco","year":"2018","unstructured":"Monaco SA, Ferguson BR, Gao WJ. Lithium inhibits GSK3beta and augments GluN2A receptor expression in the Prefrontal Cortex. Front Cell Neurosci. 2018;12:16.","journal-title":"Front Cell Neurosci"},{"key":"636_CR334","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainresbull.2017.10.015","volume":"137","author":"R Mohammad Jafari","year":"2018","unstructured":"Mohammad Jafari R, Ghahremani MH, Rahimi N, Shadboorestan A, Rashidian A, Esmaeili J, Ejtemaei Mehr S, Dehpour AR. The anticonvulsant activity and cerebral protection of chronic lithium chloride via NMDA receptor\/nitric oxide and phospho-ERK. Brain Res Bull. 2018;137:1\u20139.","journal-title":"Brain Res Bull"},{"key":"636_CR335","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.bbrc.2013.03.047","volume":"434","author":"B Bosche","year":"2013","unstructured":"Bosche B, Schafer M, Graf R, Hartel FV, Schafer U, Noll T. Lithium prevents early cytosolic calcium increase and secondary injurious calcium overload in glycolytically inhibited endothelial cells. Biochem Biophys Res Commun. 2013;434:268\u201372.","journal-title":"Biochem Biophys Res Commun"},{"key":"636_CR336","doi-asserted-by":"crossref","unstructured":"Shim SS, LAM, Kapecki N, Briggs CA, Stutzmann GE. Lithium suppresses calcium signaling, nitrosative stress and tauopathy and enhances synaptic plasticity in 3xTg-AD mice. Alzheimer\u2019s Association International Conference 2019, Abstract:32321.","DOI":"10.1016\/j.jalz.2019.06.737"},{"key":"636_CR337","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1089\/neu.2015.4177","volume":"33","author":"SS Shim","year":"2016","unstructured":"Shim SS, Stutzmann GE. Inhibition of glycogen synthase Kinase-3: an emerging target in the treatment of traumatic brain Injury. J Neurotrauma. 2016;33:2065\u201376.","journal-title":"J Neurotrauma"},{"key":"636_CR338","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.pharmthera.2016.02.009","volume":"160","author":"A Hoque","year":"2016","unstructured":"Hoque A, Hossain MI, Ameen SS, Ang CS, Williamson N, Ng DC, Chueh AC, Roulston C, Cheng HC. A beacon of hope in stroke therapy-blockade of pathologically activated cellular events in excitotoxic neuronal death as potential neuroprotective strategies. Pharmacol Ther. 2016;160:159\u201379.","journal-title":"Pharmacol Ther"},{"key":"636_CR339","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.expneurol.2018.02.015","volume":"305","author":"JH Lee","year":"2018","unstructured":"Lee JH, Zhang JY, Wei ZZ, Yu SP. Impaired social behaviors and minimized oxytocin signaling of the adult mice deficient in the N-methyl-d-aspartate receptor GluN3A subunit. Exp Neurol. 2018;305:1\u201312.","journal-title":"Exp Neurol"},{"key":"636_CR340","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.neuropharm.2008.07.046","volume":"55","author":"K Yashiro","year":"2008","unstructured":"Yashiro K, Philpot BD. Regulation of NMDA receptor subunit expression and its implications for LTD, LTP, and metaplasticity. Neuropharmacology. 2008;55:1081\u201394.","journal-title":"Neuropharmacology"},{"key":"636_CR341","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1177\/1073858411435129","volume":"19","author":"A Sanz-Clemente","year":"2013","unstructured":"Sanz-Clemente A, Nicoll RA, Roche KW. Diversity in NMDA receptor composition: many regulators, many consequences. Neuroscientist. 2013;19:62\u201375.","journal-title":"Neuroscientist"},{"key":"636_CR342","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/jcp.21902","volume":"221","author":"MS Arrazola","year":"2009","unstructured":"Arrazola MS, Varela-Nallar L, Colombres M, Toledo EM, Cruzat F, Pavez L, Assar R, Aravena A, Gonzalez M, Montecino M, et al. Calcium\/calmodulin-dependent protein kinase type IV is a target gene of the Wnt\/beta-catenin signaling pathway. J Cell Physiol. 2009;221:658\u201367.","journal-title":"J Cell Physiol"},{"key":"636_CR343","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/88380","volume":"4","author":"GE Hardingham","year":"2001","unstructured":"Hardingham GE, Arnold FJ, Bading H. A calcium microdomain near NMDA receptors: on switch for ERK-dependent synapse-to-nucleus communication. Nat Neurosci. 2001;4:565\u20136.","journal-title":"Nat Neurosci"},{"key":"636_CR344","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1073\/pnas.051634198","volume":"98","author":"GY Wu","year":"2001","unstructured":"Wu GY, Deisseroth K, Tsien RW. Activity-dependent CREB phosphorylation: convergence of a fast, sensitive calmodulin kinase pathway and a slow, less sensitive mitogen-activated protein kinase pathway. Proc Natl Acad Sci U S A. 2001;98:2808\u201313.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"636_CR345","doi-asserted-by":"crossref","unstructured":"Screaton RA, Conkright MD, Katoh Y, Best JL, Canettieri G, Jeffries S, Guzman E, Niessen S, Yates JR 3rd, Takemori H, et al. The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector. Cell. 2004;119:61\u201374.","DOI":"10.1016\/j.cell.2004.09.015"},{"key":"636_CR346","doi-asserted-by":"publisher","first-page":"4420","DOI":"10.1523\/JNEUROSCI.0802-09.2009","volume":"29","author":"D Lau","year":"2009","unstructured":"Lau D, Bading H. Synaptic activity-mediated suppression of p53 and induction of nuclear calcium-regulated neuroprotective genes promote survival through inhibition of mitochondrial permeability transition. J Neurosci. 2009;29:4420\u20139.","journal-title":"J Neurosci"},{"key":"636_CR347","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1523\/JNEUROSCI.5115-09.2010","volume":"30","author":"F Leveille","year":"2010","unstructured":"Leveille F, Papadia S, Fricker M, Bell KF, Soriano FX, Martel MA, Puddifoot C, Habel M, Wyllie DJ, Ikonomidou C, et al. Suppression of the intrinsic apoptosis pathway by synaptic activity. J Neurosci. 2010;30:2623\u201335.","journal-title":"J Neurosci"},{"key":"636_CR348","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/365855a0","volume":"365","author":"JC Chrivia","year":"1993","unstructured":"Chrivia JC, Kwok RP, Lamb N, Hagiwara M, Montminy MR, Goodman RH. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature. 1993;365:855\u20139.","journal-title":"Nature"},{"key":"636_CR349","doi-asserted-by":"publisher","first-page":"233","DOI":"10.4161\/chan.3.4.9381","volume":"3","author":"B Al-Mubarak","year":"2009","unstructured":"Al-Mubarak B, Soriano FX, Hardingham GE. Synaptic NMDAR activity suppresses FOXO1 expression via a cis-acting FOXO binding site: FOXO1 is a FOXO target gene. Channels (Austin). 2009;3:233\u20138.","journal-title":"Channels (Austin)"},{"key":"636_CR350","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1126\/science.1056784","volume":"291","author":"FC Nucifora Jr","year":"2001","unstructured":"Nucifora FC Jr, Sasaki M, Peters MF, Huang H, Cooper JK, Yamada M, Takahashi H, Tsuji S, Troncoso J, Dawson VL, et al. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science. 2001;291:2423\u20138.","journal-title":"Science"},{"key":"636_CR351","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/s41419-020-2605-y","volume":"11","author":"HT Lu","year":"2020","unstructured":"Lu HT, Feng RQ, Tang JK, Zhou JJ, Gao F, Ren J. CaMKII\/calpain interaction mediates ischemia\/reperfusion injury in isolated rat hearts. Cell Death Dis. 2020;11:388.","journal-title":"Cell Death Dis"},{"key":"636_CR352","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.nbd.2014.11.015","volume":"74","author":"VS Van Laar","year":"2015","unstructured":"Van Laar VS, Roy N, Liu A, Rajprohat S, Arnold B, Dukes AA, Holbein CD, Berman SB. Glutamate excitotoxicity in neurons triggers mitochondrial and endoplasmic reticulum accumulation of parkin, and, in the presence of N-acetyl cysteine, mitophagy. Neurobiol Dis. 2015;74:180\u201393.","journal-title":"Neurobiol Dis"},{"key":"636_CR353","doi-asserted-by":"publisher","first-page":"04","DOI":"10.3389\/fnagi.2018.00004","volume":"10","author":"MS Uddin","year":"2018","unstructured":"Uddin MS, Stachowiak A, Mamun AA, Tzvetkov NT, Takeda S, Atanasov AG, Bergantin LB, Abdel-Daim MM, Stankiewicz AM. Autophagy and Alzheimer\u2019s Disease: from Molecular Mechanisms to therapeutic implications. Front Aging Neurosci. 2018;10:04.","journal-title":"Front Aging Neurosci"},{"key":"636_CR354","doi-asserted-by":"publisher","first-page":"e240","DOI":"10.1038\/cddis.2011.117","volume":"2","author":"D Nguyen","year":"2011","unstructured":"Nguyen D, Alavi MV, Kim KY, Kang T, Scott RT, Noh YH, Lindsey JD, Wissinger B, Ellisman MH, Weinreb RN, et al. A new vicious cycle involving glutamate excitotoxicity, oxidative stress and mitochondrial dynamics. Cell Death Dis. 2011;2:e240.","journal-title":"Cell Death Dis"},{"key":"636_CR355","doi-asserted-by":"publisher","first-page":"102113","DOI":"10.1016\/j.pneurobio.2021.102113","volume":"204","author":"Y Xia","year":"2021","unstructured":"Xia Y, Wang ZH, Zhang Z, Liu X, Yu SP, Wang JZ, Wang XC, Ye K. Delta- and beta- secretases crosstalk amplifies the amyloidogenic pathway in Alzheimer\u2019s disease. Prog Neurobiol. 2021;204:102113.","journal-title":"Prog Neurobiol"},{"key":"636_CR356","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","volume":"12","author":"CR Jack Jr","year":"2013","unstructured":"Jack CR Jr, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, Shaw LM, Vemuri P, Wiste HJ, Weigand SD, et al. Tracking pathophysiological processes in Alzheimer\u2019s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013;12:207\u201316.","journal-title":"Lancet Neurol"},{"key":"636_CR357","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1056\/NEJMoa013128","volume":"348","author":"B Reisberg","year":"2003","unstructured":"Reisberg B, Doody R, Stoffler A, Schmitt F, Ferris S, Mobius HJ. Memantine Study G: Memantine in moderate-to-severe Alzheimer\u2019s disease. N Engl J Med. 2003;348:1333\u201341.","journal-title":"N Engl J Med"},{"key":"636_CR358","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1159\/000079833","volume":"18","author":"R Doody","year":"2004","unstructured":"Doody R, Wirth Y, Schmitt F, Mobius HJ. Specific functional effects of memantine treatment in patients with moderate to severe Alzheimer\u2019s disease. Dement Geriatr Cogn Disord. 2004;18:227\u201332.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"636_CR359","doi-asserted-by":"publisher","first-page":"101758","DOI":"10.1016\/j.arr.2022.101758","volume":"82","author":"E Profyri","year":"2022","unstructured":"Profyri E, Leung P, Huntley J, Orgeta V. Effectiveness of treatments for people living with severe dementia: a systematic review and meta-analysis of randomised controlled clinical trials. Ageing Res Rev. 2022;82:101758.","journal-title":"Ageing Res Rev"},{"key":"636_CR360","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1002\/gps.2766","volume":"27","author":"R Hellweg","year":"2012","unstructured":"Hellweg R, Wirth Y, Janetzky W, Hartmann S. Efficacy of memantine in delaying clinical worsening in Alzheimer\u2019s disease (AD): responder analyses of nine clinical trials with patients with moderate to severe AD. Int J Geriatr Psychiatry. 2012;27:651\u20136.","journal-title":"Int J Geriatr Psychiatry"},{"key":"636_CR361","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1111\/bph.14763","volume":"176","author":"F Luo","year":"2019","unstructured":"Luo F, Wu L, Zhang Z, Zhu Z, Liu Z, Guo B, Li N, Ju J, Zhou Q, Li S, et al. The dual-functional memantine nitrate MN-08 alleviates cerebral vasospasm and brain injury in experimental subarachnoid haemorrhage models. Br J Pharmacol. 2019;176:3318\u201335.","journal-title":"Br J Pharmacol"},{"key":"636_CR362","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3389\/fnmol.2019.00163","volume":"12","author":"A Duthie","year":"2019","unstructured":"Duthie A, van Aalten L, MacDonald C, McNeilly A, Gallagher J, Geddes J, Lovestone S, Sutherland C. Recruitment, Retainment, and biomarkers of response; a pilot trial of Lithium in humans with mild cognitive impairment. Front Mol Neurosci. 2019;12:163.","journal-title":"Front Mol Neurosci"},{"key":"636_CR363","doi-asserted-by":"publisher","first-page":"e672","DOI":"10.4088\/JCP.13m08741","volume":"75","author":"I Aprahamian","year":"2014","unstructured":"Aprahamian I, Santos FS, dos Santos B, Talib L, Diniz BS, Radanovic M, Gattaz WF, Forlenza OV. Long-term, low-dose lithium treatment does not impair renal function in the elderly: a 2-year randomized, placebo-controlled trial followed by single-blind extension. J Clin Psychiatry. 2014;75:e672\u2013678.","journal-title":"J Clin Psychiatry"},{"key":"636_CR364","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1192\/bjp.bp.110.080044","volume":"198","author":"OV Forlenza","year":"2011","unstructured":"Forlenza OV, Diniz BS, Radanovic M, Santos FS, Talib LL, Gattaz WF. Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial. Br J Psychiatry. 2011;198:351\u20136.","journal-title":"Br J Psychiatry"},{"key":"636_CR365","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/ana.21597","volume":"65","author":"ML Berthier","year":"2009","unstructured":"Berthier ML, Green C, Lara JP, Higueras C, Barbancho MA, Davila G, Pulvermuller F. Memantine and constraint-induced aphasia therapy in chronic poststroke aphasia. Ann Neurol. 2009;65:577\u201385.","journal-title":"Ann Neurol"},{"key":"636_CR366","first-page":"591","volume":"13","author":"H Kafi","year":"2014","unstructured":"Kafi H, Salamzadeh J, Beladimoghadam N, Sistanizad M, Kouchek M. Study of the neuroprotective effects of memantine in patients with mild to moderate ischemic stroke. Iran J Pharm Res. 2014;13:591\u20138.","journal-title":"Iran J Pharm Res"},{"key":"636_CR367","doi-asserted-by":"publisher","first-page":"11","DOI":"10.18869\/acadpub.cjns.1.3.11","volume":"1","author":"MH Babak Bakhshayesh-Eghbali","year":"2015","unstructured":"Babak Bakhshayesh-Eghbali MH, Seyed-Mohammad Seyed-Saadat S-N, Kazemnezhad-Leili S-SE. Melina Rouhi-Rad: comparing the Effect of Memantine and Placebo on Clinical Outcome of Intracranial Hemorrhage: a Randomized double blind clinical trial. Casp J Neurol Sci. 2015;1:11\u20138.","journal-title":"Casp J Neurol Sci"},{"key":"636_CR368","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jocn.2021.06.005","volume":"90","author":"N Beladi Moghadam","year":"2021","unstructured":"Beladi Moghadam N, Pourheidar E, Ahmadpour F, Kafi H, Salamzadeh J, Nasiri S, Sistanizad M. The effects of memantine on the serum concentrations of matrix metalloproteinases and neurologic function of patients with ischemic stroke. J Clin Neurosci. 2021;90:268\u201372.","journal-title":"J Clin Neurosci"},{"key":"636_CR369","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1111\/bdi.12336","volume":"17","author":"CC Lan","year":"2015","unstructured":"Lan CC, Liu CC, Lin CH, Lan TY, McInnis MG, Chan CH, Lan TH. A reduced risk of stroke with lithium exposure in bipolar disorder: a population-based retrospective cohort study. Bipolar Disord. 2015;17:705\u201314.","journal-title":"Bipolar Disord"},{"key":"636_CR370","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1186\/s13063-018-2746-9","volume":"19","author":"JM Hong","year":"2018","unstructured":"Hong JM, Choi MH, Sohn SI, Hwang YH, Ahn SH, Lee YB, Shin DI, Chamorro A, Choi DW. On the behalf of the Si: Safety and Optimal Neuroprotection of neu2000 in acute ischemic stroke with reCanalization: study protocol for a randomized, double-blinded, placebo-controlled, phase-II trial. Trials. 2018;19:375.","journal-title":"Trials"},{"key":"636_CR371","doi-asserted-by":"publisher","first-page":"1096372","DOI":"10.3389\/fnins.2023.1096372","volume":"17","author":"D Pichardo-Rojas","year":"2023","unstructured":"Pichardo-Rojas D, Pichardo-Rojas PS, Cornejo-Bravo JM, Serrano-Medina A. Memantine as a neuroprotective agent in ischemic stroke: preclinical and clinical analysis. Front Neurosci. 2023;17:1096372.","journal-title":"Front Neurosci"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-023-00636-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-023-00636-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-023-00636-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T03:50:10Z","timestamp":1702698610000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-023-00636-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,3]]},"references-count":371,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["636"],"URL":"https:\/\/doi.org\/10.1186\/s13024-023-00636-1","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,3]]},"assertion":[{"value":"12 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable:","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}